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enyl)cyclopentyl)methanol : 5 
To a solution of the lactone 4 (2 g, 5 mmol, 1.0 eq) in CH2Cl2 (100 mL) at -78°C, was added 
dropwise the solution of Dibal-H (1.2 M in toluene, 6.2 mL, 7.5 mmol, 1.5 eq). After 30 min at -
78°C, 100 mL of a solution of 1M Rochelle salt were added. The mixture was stirred during 3 
hours. The layers were separated and the aqueous one was extracted with 3 x 50 mL of CH2Cl2. 
The combined organic layers were extracted with 2 x 50 mL of brine and dried over MgSO4, 
filtered and the solvents removed under reduced pressure. The lactol was obtained as colourless 
oil and directly used in the next step without further purification.  
To a suspension of the (n-propyl) triphenyl-phosphonium bromide (6.42 g, 16.6 mmol, 3.2 eq) in 
THF (70 mL), at 0 °C, was added dropwise tBuOK (1 M in THF, 15.6 mL, 15.6 mmol, 3 eq). 
After 30 min at 0 °C, the mixture was canulated into the lactol solution (5 mmol, 1.0 eq) in THF 
(25 mL) at 0°C. The reaction was stirred 30 min. Then, 100 mL of brine were added. The layers 
were separated and the aqueous one extracted with 3 x 100 mL of Et2O. The combined organic 
layers were washed with 2 x 50 mL of brine and dried over MgSO4, filtered and the solvents 
removed under reduced pressure. The crude of the reaction was purified under silica gel 
chromatography (97.5/2.5 to 90/10: Pentane/ Et2O) and the compound 5 was obtained as an oil 
(2.01 g, 94%, 2 steps). Rf = 0.6 (8/2: Cyclohexane/AcOEt); [α]D20= -+5 (c= 5, CHCl3); IR (neat) : 
ν= 3432 cm-1 (OH) ; 1H NMR (300 MHz, CDCl3): δ= 5.44-5.27 (m, 4H); 4.02 (q, 3J(H,H) = 7.2 
Hz, 1H); 3.82-3.77 (m, 1H); 3.73-3.60 (m, 2H); 2.34-2.25 (m, 2H); 2.07-1.91 (m, 5H); 1.71 (ls, 
1H, OH); 1.51 (dt, 3J(H,H) = 13.4, 5.8 Hz, 1H); 0.95 (t, 3J(H,H) = 7.5 Hz, 1H); 8.86 (s, 18H); 
0.03 (s, 6H); 0.00 (s, 6H); 13C NMR (75 MHz, CDCl3): δ= 132.6 (CH); 127.7 (CH); 75.6 
(CHOH); 75.0 (CHOH); 62.6 (CH2OH); 50.1 (CH); 48.2 (CH); 44.4 (CH2); 25.7 (CH2); 25.6 
(CH3); 20.6 (CH2); 17.9 (Cquat); 17.8 (Cquat); 14.0 (CH3); -4.3 (CH3); -4.5 (CH3); -4.8 (CH3); -
4.9 (CH3); HRMS (ESI+) calculated for C23H49O3Si2 [M+H]+ 429.3220, found 429.3234. 
(E)-3-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-enyl)cyclopentyl)-1-
(trimethylsilyl)prop-2-en-1-one : 6  
To a solution of the alcohol 5 (2 g, 4.66 mmol, 1.0 eq) in CH2Cl2 (50 mL), was added dropwise 
the Dess-Martin periodinane (15% w/w in CH2Cl2, 14.9 mL, 6.9 mmol, 1.5 eq). After 0.5 hour at 
room temperature, 150 mL of a solution of NaHCO3/Na2S2O3 (1/1: v/v; 10%) were added. The 
layers were stirred 2 hours and separated. The aqueous phase was extracted with 3 x 100 mL of 
Et2O. The combined organic layers were extracted with 2 x 50 mL of brine and dried over 
MgSO4, filtered and the solvents removed under reduced pressure. The aldehyde was obtained as 
colorless oil and directly used in the next step without further purification. 
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To a solution of diisopropylamine (496 µl, 3.53 mmol, 2.4 eq) in THF (5 mL) at 0°C was added a 
solution of BuLi (2.5 M in Hexane, 1.23 mL, 3.085 mmol, 2.1 eq). The mixture was stirred for 30 
min, treated with a solution of [(trimethylsilyl)acetyl]trimethylsilane (608 mg, 3.23 mmol, 1.2 eq) 
in THF (10 mL) and re-stirred 30 min. The mixture was treated at -78°C with a solution of 
aldehyde (626 mg, 1.46 mmol, 1 eq) in THF (10 mL). The resulting mixture was stirred 30 min at 
– 78°C. A saturated solution of NH4Cl (25 mL) were added, and the layers were separated. The 
aqueous layer was extracted with 3 x 25 mL of Et2O. The combined organic layers were washed 
with 25 mL of brine, dried over MgSO4, filtered and the solvents removed under reduced 
pressure. The crude of the reaction was purified under silica gel chromatography (9/1: 
Cyclohexane/ Et2O) and 6 (655 mg, 85%, 2 steps) was obtained as a colorless oil. Rf = 0.66 
(9.5/.5: Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 6.58 (dd, 3J(H,H) = 9.6, 15.9 Hz, 
1H); 6.28 (d, 3J(H,H) = 15.9 Hz, 1H); 5.42-5.20 (m, 2H); 3.99 (q, 3J(H,H) = 6.6 Hz 1H), 3.85 (q, 
3J(H,H) = 6.3 Hz, 1H); 2.83 (q, 3J(H,H) = 5.7 Hz, 1H); 2.35 (dt, 3J(H,H) = 13.9, 6.9 Hz, 1H); 2.16 
(quint, 3J(H,H) = 6.2 Hz, 1H); 2.10-1.79 (m, 4H); 1.58 (m, 1H); 0.91 (t, 3J(H,H) = 7.5 Hz, 3H); 
0.86 (s, 9H); 0.83 (s, 9H); 0.23 (s, 9H); 0.02 (s, 6H); -0.01 (s, 3H); -003 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ= 146.4 (CH); 137.1 (CH); 132.8 (CH); 126.9 (CH); 75.5 (CHOH); 75.4 
(CHOH); 53.0 (CH); 50.9 (CH); 44.3 (CH2); 26.2 (CH2); 25.7 (CH3); 20.6 (CH2); 17.9 (Cquat); 
14.0 (CH3); -2.2 (CH3); -4.5 (CH3); -4.6 (CH3); -4.7 (CH3); -4.8 (CH3); -9.0 (Cquat). 
(E)-methyl 10-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)-8-hydroxy-8-(trimethylsilyl)dec-9-en-5-ynoate : 7 
A solution of (7-methoxy-7-oxohept-2-ynyl)zinc(II) bromide, was prepared from zinc dust (572 
mg, 8.74 mmol, 7 eq), 1,2 dibromoethane (75µl, 0.87 mmol, 0.7 eq) and methyl 7-bromohept-5-
ynoate (1.37 g, 6.25 mmol, 5 eq) in THF (20 mL) at 0°C. The mixture was stirred 2 hours and 
added to a solution of 6 (655 mg, 1.25 mmol, 1 eq) in THF (13 mL). The mixture was heated 
around 30°C for 30 min. 50 mL of a saturated solution of NH4Cl were added, and the layers were 
separated. The aqueous layer was extracted with 3 x 50 mL of Et2O. The combined organic layers 
were washed with 2 x 50 mL of brine, dried over MgSO4, filtered and the solvents removed under 
reduced pressure. The crude of the reaction was purified under silica gel chromatography (98/2 to 
95/5: pentane/Et2O) and 7 (602 mg, 73%) was obtained. Rf = 0.25 (9.5/.5: Cyclohexane/AcOEt); 
IR (neat) : ν= 3503 cm-1 (OH), 1741 cm-1 (C=O);  1H NMR (300 MHz, CDCl3): δ= 5.43 (dd, 
3J(H,H) = 11.9, 15.4, 1H); 5.37-5.21 (m, 3H); 3.92-3.78 (m, 2H); 3.65-3.64 (m, 3H); 2.65-2.63 
(m, 1H); 2.53-2.30 (m, 5H); 2.21-1.97 (m, 6H); 1.89-1.70 (m, 4H); 1.55-1.48 (m, 1H); 0.92 (t, 
3J(H,H) = 7.5 Hz, 3H); 0.86 (s, 9H), 0.84 (s, 9H); 0.02-0.00 (m, 21H); 13C NMR (75 MHz, 
CDCl3): δ= 173.8 (Cquat); 136.1 (CH); 135.9 (CH); 131.9 (CH); 131.6 (CH); 127.8 (CH); 127.7 
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(CH); 126.0 (CH); 82.9 (Cquat); 82.7 (Cquat); 76.7 (Cquat); 76.2 (CHOH); 75.9 (CHOH); 68.8 
(CHOH); 68.7 (CHOH); 53.1 (CH); 52.8 (CH); 51.4 (CH); 50.2 (CH); 44.3 (CH2); 44.2 (CH2); 
32.9 (CH2); 28.8 (CH2); 28.7 (CH2); 25.9 (CH2); 25.8 (CH2); 25.7 (CH3); 24.1 (CH2); 24.0 (CH2); 
20.6 (CH2); 20.5 (CH2); 18.2 (Cquat); 17.9 (Cquat); 14.2 (CH3); 14.1 (CH3); -4.0 (CH3); -
4,1(CH3); -4.4 (CH3); -4.5 (CH3); -4.6 (CH3); -4.8 (CH3). 
(E)-3-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-enyl) cyclopentyl) 
acrylaldehyde : 9 
To a solution of the alcohol 5 (2 g, 4.66 mmol, 1 eq) in CH2Cl2 (50 mL), was added dropwise the 
Dess-Martin periodinane (15% w/w in CH2Cl2, 14.9 mL, 6.90 mmol, 1.5 eq). After 0.5 hour at 
room temperature, 150 mL of a solution of NaHCO3/Na2S2O3 (1/1: v/v; 10%) were added. The 
layers were stirred 2 hours and separated. The aqueous phase was extracted with 3 x 100 mL of 
Et2O. The combined organic layers were extracted with 2 x 50 mL of brine and dried over 
MgSO4, filtered and the solvents removed under reduced pressure. The aldehyde was obtained as 
colorless oil and directly used in the next step without further purification. 
 
To a solution of the aldehyde in THF (50 mL) was added methyl(triphenylphosphoranylidene)-
acetate (3.25 g, 9.32 mmole, 2 eq) at room temperature. The mixture was stirred 2 days. Celite ® 
was added and the solvents were removed under reduced pressure. The crude of the reaction was 
purified under silica gel chromatography (97.5/2.5: Pentane/Et2O) and the ester (1.74 g, 75%) 
was obtained. Rf = 0.6 (8/2: Cyclohexane/AcOEt); [α]D20= -5.4 (c= 5, CHCl3) ; IR (neat) : ν= 
1721cm-1 (C=O) 1651 cm-1, (C=C); 1H NMR (300 MHz, CDCl3): δ= 6.76 (dd, 3J(H,H) =10.0, 
15.5 Hz, 1H); 5.82 (dd, 3J(H,H) = 0.9, 15.5 Hz, 1H); 5.38-5.21 (m, 2H); 4.17 (dq, 3J(H,H) = 1.0, 
7.1 Hz, 2H); 3.99-3.95 (m, 1H); 3.84 (q, 3J(H,H) =6.0 Hz, 1H); 2.79-2.74 (m, 1H); 2.35 (dt, 
3J(H,H) = 6.9, 13.8 Hz, 1H); 2.20-1.83 (m, 5H); 1.57-1.53 (m, 1H); 1.26 (t, 3J(H,H) = 7.1 Hz, 
3H); 0.92 (t, 3J(H,H) = 7.4 Hz, 3H); 0.87 (s, 9H); 0.84 (s, 9H); 0.01 (s, 6H); -0.01 (s, 3H); -0.02 
(s, 3H); 13C NMR (75 MHz, CDCl3): δ= 166.3 (Cquat); 147.5 (CH); 132.5 (CH); 127.1 (CH); 
122.8 (CH); 75.6 (CHOH); 75.2 (CHOH); 60.0 (CH2OH); 52.6 (CH); 50.5 (CH); 44.2 (CH2); 
26.2 (CH2); 25.7 (CH3); 20.6 (CH2); 17.8 (Cquat); 14.2 (CH3); 14.0 (CH3); -4.5 (CH3); -4.7 
(CH3); -4.8 (CH3); ); HRMS (ESI+) calculated for C27H53O4Si2 [M+H]+ 497.3482, found 
497.3459. 
 
To a solution of the ester (1.7 g, 3.5 mmol, 1 eq) in CH2Cl2 (35 mL) at -78°C, was added 
dropwise the solution of Dibal-H (1 M in heptane, 7.7 mL, 7.7 mmol, 2.2 eq). After 30 min at -
78°C, 60 mL of a solution of 1M Rochelle salt were added. The mixture was stirred during 3 
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hours. The layers were separated and the aqueous one was extracted with 3 x 50 mL of Et2O. The 
combined organic layers were washed with 3 x 25 mL of brine and dried over MgSO4, filtered 
and the solvents removed under reduced pressure. The allylic alcohol (1.69 g) with solvent’s 
traces was directly used in the next step without further purification. Rf = 0.35 (3/1 : 
Cyclohexane/AcOEt); IR (neat) : ν= 3342cm-1 (OH); 1H NMR (300 MHz, CDCl3): δ= 5.67 (dt, 
3J(H,H) = 5.6, 15.3 Hz, 1H); 5.49 (dd, 3J(H,H) = 9.5, 15.3 Hz, 1H); 5.38-5.25 (m, 2H); 4.09 (d, 
3J(H,H) = 5.6 Hz, 2H); 3.89 (dt, 3J(H,H) = 4.8, 7.0 Hz, 1H); 3.79 (q, 3J(H,H) = 5.7 Hz, 1H); 2.68-
2.61 (m, 1H); 2.30 (dt, 3J(H,H) = 7.2 Hz, 2J(H,H) = 13.7 Hz, 1H); 2.11-1.88 (m, 5H); 1.52 (dt, 
3J(H,H) = 5.3 Hz, 2J(H,H) = = 13.7 Hz, 1H); 0.93 (t, 3J(H,H) = 7.2 Hz, 3H); 0.86 (s, 9H); 0.84 s, 
9H); 0.00 (s, 6H); -0.01 (s, 3H); -0.02 (s, 3H); ); 13C NMR (75 MHz, CDCl3): δ=132.0 (CH); 
131.2 (CH); 130.9 (CH); 127.7 (CH); 76.0 (CHOH); 75.7 (CHOH); 63.5 (CH2OH); 52.4 (CH); 
50.1 (CH); 44.1 (CH2); 26.1 (CH2); 25.7 (CH3); 20.6 (CH2); 17.9 (Cquat); 17.8 (Cquat); 14.1 
(CH3); -4.5 (CH3); -4.6 (CH3); -4.8 (CH3); HRMS (ESI+) calculated for C25H51O3Si2 [M+H]+ 
455.3377, found 455.3378. 
 
To a solution of the allylic alcohol (“3.5 mmol”) in CH2Cl2 (35 mL), was added dropwise the 
Dess-Martin periodinane (15% w/w in CH2Cl2, 11.4 mL, 5.25 mmol, 1.5 eq). After 0.5 hour at 
room temperature, 100 mL of a solution of NaHCO3/Na2S2O3 (1/1: v/v; 10%) were added. The 
layers were stirred 2 hours and separated. The aqueous phase was extracted with 3 x 100 mL of 
Et2O. The combined organic layers were extracted with 2 x 50 mL of brine and dried over 
MgSO4, filtered and the solvents removed under reduced pressure. The aldehyde 9 (1.42 g, 92%), 
was directly used in the next step without further purification. Rf = 0.45 (9/1 : 
Cyclohexane/AcOEt); [α]D20= +4.5 (c= 2, CHCl3) ; IR (neat) : ν= 1693 cm-1 (C=O), 1634 cm-1 
(C=C); 1H NMR (300 MHz, CDCl3): δ= 9.49 (d, 3J(H,H) = 7.8 Hz, 1H); 6.69 (dd, 3J(H,H) = 9.3, 
15.6 Hz, 1H); 6.13 (dd, 3J(H,H) = 7.8, 15.6 Hz, 1H); 5.40-5.20 (m, 2H); 4.04 (dt, 3J(H,H) = 5.5, 
7.2 Hz, 1H); 3.86 (q, 3J(H,H) = 6.8 Hz, 1H); 3.00-2.93 (m, 1H), 2.37 (dt, 3J(H,H) = 7.1 Hz, 
2J(H,H) = 13.8 Hz, 1H); 2.23-2.15 (m, 1H); 2.05-1.87 (m, 4H); 1.60 (dt, 3J(H,H) = 5.3 Hz, 
2J(H,H) = 13.8 Hz, 1H); 0.93 (t, 3J(H,H) =5.6 Hz, 3H); 0.86 (s, 9H); 0.83 (s, 9H); 0.02 (s, 6H); 
0.00 (s, 3H); -0.04 (s, 3H); 13C NMR (75 MHz, CDCl3): δ=193.4 (CHO); 157.1 (CH); 134.2 
(CH); 132.8 (CH); 126.8 (CH); 75.4 (CHOH); 75.1 (CHOH); 52.9 (CH); 50.8 (CH); 44.2 (CH2); 
26.2 (CH2); 25.7 (CH3); 25.6 (CH3); 20.6 (CH2); 17.8 (Cquat); 14.1 (CH3); -4.5 (CH3); -4.6 





1-en-5-yn-3-ol 10 : 
To a solution of the aldehyde 9 (1.2 g, 2.6 mmol, 1 eq), in Et2O (20 mL), was added a freshly 
prepared solution of propargyl magnesium bromide (0.5 M in Et2O, 10.5 mL, 5.25 mmol, 2 eq) at 
0°C. After 3 hours at the same temperature, HCl (0.1 M, 50 mL) was added and the mixture was 
stirred 1 hour. The layers were separated. The crude of the reaction was purified by flash 
chromatography (98/2 to 96/4 Pentane/Et2O) and the propargyl alcohol 10 was obtained as an oil 
(1.38 g, 80%). Rf = 0.54 (8/2 : Cyclohexane/AcOEt); IR (neat) : ν= 3420 cm-1 (OH), 3314 cm-1 
(C≡C); 1H NMR (300 MHz, CDCl3): δ= 5.62-5.52(m, 2H); 5.39-5.24 (m, 2H); 4.19-4.27 (m, 
1H); 3.79 (q, 3J(H,H) = 6.7 Hz, 1H); 2.68-2.61 (m, 1H); 2.44-2.39 (m, 2H); 2.31 (dtd, 3J(H,H) = 
1.3, 7.2 Hz, 2J(H,H) = 13.9 Hz, 1H); 2.09-1.82 (m, 7H); 1.56-1.40 (m, 1H); 0.93 (dt, 3J(H,H) = 
1.0, 7.4 Hz, 3H); 0.90 (s, 9H); 0.84 (s, 9H); 0.00 (s, 12H); 13C NMR (75 MHz, CDCl3): δ= 132.7 
(CH); 132.0 (2xCH); 131.2 (CH); 131.0 (CH); 127.7 (CH); 80.3 (Cquat); 75.9 (2xCHOH); 75.7 
(CHOH); 75.6 (CHOH); 70.7 (≡CH); 70.5 (CHOH); 52.3 (CH); 52.2 (CH); 50.2 (CH); 44.2 
(CH2); 27.6 (CH2); 26.0 (CH2); 25.7 (CH3); 20.6 (CH2); 17.9 (Cquat); 17.8 (Cquat); 14.1 (CH3); -
4.5 (CH3); -4.6 (2 x CH3); -4.8 (CH3); HRMS (ESI+) calculated for C28H53O3Si2 [M+H]+ 
493.3533, found 493.3532. 
 
(S)-((E)-1-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)hex-1-en-5-yn-3-yloxy)(phenyl)methyl acetate : 11 
To a solution of alcohol 10 (1.33 g, 2.8 mmol, 1 eq) in CH2Cl2 (56 mL), at room temperature, 
were added (S)-acetyl phenyl acetic acid (1.09 g, 5.6 mmol, 2 eq), EDCI (1.1g, 5.6 mmol, 2 eq) 
and DMAP (137 mg, 1.1 mmol, 0.4 eq). After 1.5 hour, a saturated solution of NaCl (80 mL) was 
added. The layers were separated and the aqueous one was extracted with 3 x 80 mL of Et2O. The 
combined organic layers were washed with 2 x 40 mL of brine, dried over MgSO4, filtered and 
the solvents removed under reduced pressure. The crude was purified under silica gel 
chromatography (97.5/2.5: Pentane/Et2O). the two epimers (S)-11a ( 752 mg, 40%) and (R)-11b 
(904 mg, 48%) were separated. 
11b Rf = 0.44 (8/1 : Cyclohexane/AcOEt); [α]D20= +21.5 (c= 2, CHCl3); IR (neat) : ν= 3314 
(C≡C); 1748 (C=O); 1H NMR (300 MHz, CDCl3): δ= 7.48-7.45 (m, 2H); 7.36-7.34 (m, 3H); 5.90 
(s, 1H); 5.63-5.47 (m, 2H); 5.37-5.25 (m, 3H); 3.92-3.86 (m, 1H); 3.82-3.78 (m, 1H); 2.65-2.61 
(m, 1H); 2.38-2.36 (m, 2H); 2.31 (dt, 3J(H,H) = 6.9 Hz, 2J(H,H) = 13.6 Hz, 1H); 2.16 (s, 3H); 
2.04-1.93 (m, 4H); 1.88-1.75 (m, 2H); 1.51 (dt, 3J(H,H) = 5.2 Hz, 2J(H,H) = 13.6 Hz, 1H); 0.93 (t, 
3J(H,H) = 7.5 Hz, 3H); 0.86 (s, 9H); 0.84 (s, 9H); 0.01 (s, 6H); -0.01 (s, 6H); 13C NMR (75 MHz, 
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CDCl3): δ= 170.0 (Cquat); 167.8 (Cquat); 134.1 (CH); 133.7 (Cquat); 132.1 (CH); 129.1 (CH); 
128.6 (CH); 127.7 (CH); 127.5 (CH); 127.4 (CH); 78.7 (C≡); 76.5 (CHOH); 75.7 (CHOH); 75.5 
(CHOH); 74.5 (CHOH); 73.1 (CHOH); 70.4 (CH≡); 52.4 (CH); 50.3 (CH); 44.1 (CH); 25.9 
(CH2); 25.8 (CH3); 24.5 (CH2); 20.6 (CH2 + CH3); 18.0 (Cquat); 17.9 (Cquat); 14.2 (CH3); -4.5 
(CH3); -4.6 (CH3); -4.7 (CH3); -4.8 (CH3).  
11a Rf = 0.34 (8/2 : Cyclohexane/AcOEt); [α]D20= +16 (c= 2, CHCl3); IR (neat) : ν= 3314 (C≡C); 
1748 (C=O); 1H NMR (300 MHz, CDCl3): δ= 7.45-7.43 (m, 2H); 7.36-7.33 (m, 3H); 5.92 (s, 
1H); 5.44-5.25 (m, 4H); 5.22-5.14 (m, 1H); 3.72-3.66 (m, 2H); 2.54-2.48 (m, 3H); 2.24-2.15 (m, 
4H); 2.01-1.87 (m, 5H); 1.68-1.63 (m, 1H); 1.45 (dt, 3J(H,H) = 5.4 Hz, 2J(H,H) = 13.6 Hz, 1H); 
0.93 (t, 3J(H,H) = 7.5 Hz, 3H); 0.85 (s, 9H); 0.81 (s, 9H); 0.01 (s, 3H); 0.00 (s, 3H); -0.05 (s, 3H); 
-0.07 (s, 3H); 13C NMR (75 MHz, CDCl3): δ= 170.2 (Cquat); 167.7 (Cquat); 133.9 (CH); 132.7 
(Cquat); 129.1 (CH); 128.7 (CH); 127.7 (2 x CH); 127.6 (CH); 127.4 (CH); 78.9 (C≡); 75.7 
(CHOH); 75.5 (CHOH); 74.4 (CHOH); 73.1 (CHOH); 70.7 (CH≡); 52.3 (CH); 50.4 (CH); 44.1 
(CH); 25.9 (CH2); 25.7 (CH3); 24.7 (CH2); 20.6 (CH2); 20.5 (CH3); 17.9 (2 x Cquat); 14.2 (CH3); 

































Determination of the absolute configuration and ∆δ values for the (S) and (R)-MTPA ester 





To a solution of 11a (752 mg, 1.12 mmol, 1 eq), in MeOH (25 mL), was added K2CO3 (466 mg, 
3.37 mmol, 3 eq). After 1 hour, 100 mL of brine was added. The aqueous layer was extracted 
with 3 x 100 mL of a mixture of pentane/Et2O (v/v:1/1). The combined organic layers were 
washed with 2 x 50 mL of brine, dried over MgSO4, filtered and the solvents removed under 
reduced pressure. The crude of the reaction was used directly. 
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To a solution of the allylic alcohol (1.12 mmol, 1 eq) in CH2Cl2 (10 mL), were successively 
added TBSCl (210 mg, 1.40 mmol, 1.25 eq), imidazole (190 mg, 2.8 mmol, 2.5 eq) at 0°C. After 
1 night, 50 mL of a saturated solution of NaHCO3 was added. The mixture was then extracted 
with 3 x 50 mL of Et2O. The organic layer was washed with 2 x 30 mL of a saturated solution of 
NaHCO3 and 30 mL of brine, dried over MgSO4, filtered and the solvents removed under reduced 
pressure. The crude of the reaction was purified by silica gel chromatography (99/1: 
Pentane/Et2O) and the silylated ether 13a was obtained as a colourless oil (537 mg, 79%). Rf = 
0.70 (9/1 : Cyclohexane/AcOEt); [α]D20= -1.2 (c= 5, CHCl3); IR (neat) : ν= 3316 (C≡C); 1H 
NMR (300 MHz, CDCl3): δ= 5.52-5.43 (m, 2H); 5.35-5.31 (m, 2H); 4.21 (q, 3J(H,H) = 4.9 Hz, 
1H); 3.91 (dt, 3J(H,H) = 4.2, 7.0 Hz, 1H); 3.79 (q, 3J(H,H) = 7.1 Hz, 1H); 2.65-5.68 (m, 1H); 
2.40-2.24 (m, 3H); 2.09-1.88 (m, 6H); 1.55-1.47 (m, 1H); 0.93 (t, 3J(H,H) = 7.5 Hz, 3H); 0.88 (s, 
9H); 0.87 (s, 9H); 0.85 (s, 9H); 0.06 (s, 3H); 0.03 (s, 3H), 0.00 (m, 6H); -0.01 (s, 6H); 13C NMR 
(75 MHz, CDCl3): δ= 133.6 (CH); 131.9 (CH); 129.6 (CH); 127.8 (CH); 81.4 (Cquat); 75.92 
(CHOH); 75.88 (CHOH); 72.0 (CHOH); 69.7 (CH≡); 52.0 (CH); 50.0 (CH); 44.5 (CH2); 28.6 
(CH2); 26.0 (CH2); 25.8 (CH3); 20.6 (CH2); 18.1 (Cquat); 17.9 (Cquat); 14.1 (CH3); -4.5 (CH3); -





In the same way, the silylated ether 13b was obtained as colourless oil (672 mg, 81%). Rf = 0.70 
(9/1 : Cyclohexane/AcOEt); [α]D20= -24.8 (c= 5, CHCl3); IR (neat) : ν= 3315 (C≡C); 1H NMR 
(300 MHz, CDCl3): δ= 5.45 (dd, 3J(H,H) = 7.7, 16.9 Hz, 1H); 5.36 (dd, 3J(H,H) = 5.2, 16.9 Hz); 
5.33-5.22 (m, 2H); 4.22 (q, 3J(H,H) = 5.9 Hz, 1H); 3.92 (dt, 3J(H,H) = 3.9, 6.7 Hz, 1H); 3.78 (q, 
3J(H,H) = 6.6 Hz, 1H); 2.63-2.56 (m, 1H); 2.54-2.22 (m, 3H); 2.11-1.86 (m, 6H); 1.56-1.48 (m, 
1H); 0.93 (t, 3J(H,H) = 7.5 Hz, 3H); 0.87 (s, 9H); 0.86 (s, 9H); 0.85 (s, 9H); 0.07 (s, 3H); 0.04 (s, 
3H); 0.01—0.01 (m, 12H); 13C NMR (75 MHz, CDCl3): δ= 133.7 (CH); 131.9 (CH); 129.1 (CH); 
127.8 (CH); 81.3 (Cquat); 75.94 (CHOH); 75.91 (CHOH); 71.8 (CHOH); 69.8 (CH≡); 52.3 
(CH); 50.1 (CH); 44.2 (CH2); 28.7 (CH2); 26.0 (CH2); 25.8 (CH3); 20.6 (CH2); 18.1 (Cquat); 
17.9 (Cquat); 14.1 (CH3); -4.5 (CH3); -4.6 (CH3); -4.7 (CH3); -4.8 (CH3); HRMS (ESI+) 
calculated for C34H67O3Si3 [M+H]+ 607.4398, found 607.4396. 
 
For the determination of the configuration of allylic alcohol, 11a, after saponification, was treated 
with (R)-acetyl phenyl acetic acid. 1H NMR (300 MHz, CDCl3): δ= 7.47-7.45 (m, 2H); 7.35-7.34 
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(m, 3H); 5.90 (s, 1H); 5.65-5.49 (m, 2H); 5.37-5.24 (m, 3H); 3.89-3.86 (m, 1H); 3.82-3.77 (m, 
1H); 2.67-2.61 (m, 1H); 2.39-2.37 (m, 2H); 2.30 (dt, 3J(H,H) = 6.9 Hz, 2J(H,H) = 13.5 Hz, 1H); 
2.16 (s, 3H); 2.04-1.96 (m, 4H); 1.88-1.76 (m, 2H); 1.51 (m, , 1H); 0.94 (t, 3J(H,H) = 7.5 Hz, 
3H); 0.87 (s, 9H); 0.84 (s, 9H); 0.01 (s, 6H); -0.02 (s, 6H); 13C NMR (75 MHz, CDCl3): δ= 170.0 
(Cquat); 167.8 (Cquat); 134.5 (CH); 133.7 (Cquat); 132.1 (CH); 129.0 (CH); 128.6 (CH); 127.7 
(CH); 127.5 (CH); 127.4 (CH); 78.7 (C≡); 76.5 (CHOH); 75.7 (CHOH); 75.5 (CHOH); 74.5 
(CHOH); 73.1 (CHOH); 70.4 (CH≡); 52.4 (CH); 50.4 (CH); 44.2 (CH); 25.9 (CH2); 25.8 (CH3); 
24.5 (CH2); 20.6 (CH2 + CH3); 18.0 (Cquat); 17.9 (Cquat); 14.2 (CH3); -4.5 (CH3); -4.6 (2 x 
CH3); -4.8 (CH3). 
For the same reason and the same way, 11b, after saponification, was treated with (R)-acetyl 
phenyl acetic acid. 1H NMR (300 MHz, CDCl3): δ= 7.46-7.43 (m, 2H); 7.36-7.33 (m, 3H); 5.92 
(s, 1H); 5.42-5.18 (m, 5H); 3.75-3.65 (m, 2H); 2.54-2.48 (m, 3H); 2.24-2.17 (m, 4H); 1.99-1.86 
(m, 5H); 1.74-1.61 (m, 1H); 1.45 (dt, 3J(H,H) = 5.4 Hz, 2J(H,H) = 13.6 Hz, 1H); 0.93 (t, 3J(H,H) 
= 7.5 Hz, 3H); 0.85 (s, 9H); 0.81 (s, 9H); 0.00 (s, 6H); -0.06 (s, 3H); -0.09 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ= 170.2 (Cquat); 167.7 (Cquat); 133.6 (CH); 132.0 (Cquat); 129.1 (CH); 128.7 
(CH); 127.6 (2 x CH); 127.4 (CH); 78.9 (C≡); 75.7 (CHOH); 75.5 (CHOH); 74.4 (CHOH); 73.3 
(CHOH); 70.8 (CH≡); 52.3 (CH); 50.4 (CH); 44.1 (CH); 25.9 (CH2); 25.7 (CH3); 24.8 (CH2); 
20.6 (CH2); 20.5 (CH3); 17.8 (2 x Cquat); 14.2 (CH3); -4.4 (CH3); -4.6 (2 x CH3); -4.8 (CH3). 
 
Methyl 6-bromohex-4-ynoate: 15. 
To a solution of the 4-pentynol (10 g, 119 mmol, 1 eq) and p-toluene sulfonic acid ( 565 mg, 2.9 
mmol, 0.025 eq) in CH2Cl2 (120 mL), 2,4 dihydropyran (12.35 mL, 243 mmol, 1.2 eq) diluted in 
CH2Cl2 (20 mL) were added dropwise at room temperature. The mixture was stirred all the night 
and 150 mL of saturated solution of NaHCO3 was added. The mixture was stirred 15 min and the 
layers were separated. The aqueous one was extracted with 2 x 200 mL of Et2O. The combined 
organic layers were washed with 100 mL of saturated solution of NaHCO3 and 2 x100 mL of 
brine, dried over MgSO4, filtered and the solvents removed under reduced pressure. The crude of 
the reaction was purified under silica gel chromatography (95/5: Pentane/Et2O) and the protected 
alcohol (18.9 g, 95%) was obtained. Rf = 0.5 (8/2 : Cyclohexane/AcOEt1H NMR (300 MHz, 
CDCl3): δ= 4.54 (lt, 3J(H,H) = 3.5 Hz, 1H); 3.84-3.73 (m, 2H); 3.48-3.38 (m, 2H); 2.24 (dt, 
3J(H,H) = 4.2, 11.2 Hz, 2H); 1.88 (t, 3J(H,H) = 2.7 Hz, 1H); 1.78 (quint, 3J(H,H) = 5.1 Hz, 2H); 
1.71-1.73 (m, 6H); 13C NMR (75 MHz, CDCl3): δ= 98.6 (CH(O-)2); 83.8 (C≡); 68.3 (HC≡); 65.4 
(CH2O); 62.0 (CH2O); 30.5 (CH2); 28.6 (CH2); 25.4 (CH2); 19.4 (CH2); 15.2 (CH2). 
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At room temperature, a commercial solution of methyl magnesium bromide (3M in Et2O, 42 mL, 
127 mmol, 2.0 eq) was added dropwise in a solution of alkyne (10.7 g, 63.6 mmol, 1 eq) in 
anhydrous THF (60 mL). The solution was refluxed 1.5 hour. The solution was cooled (0°C) and 
p-formaldehyde (2.86 g, 95 mmol, 1.5 eq). The reaction was refluxed two hours and p-
formaldehyde (2.4 g, 80 mmol, 1.5 eq) more was added. After refluxing overnight, the solution 
was cooled at 0°C, and Et2O (200 mL), saturated solution of NaHCO3 (100 mL) were added 
dropwise. Celite® (50 mL) was added and the mixture was filtered. The solid was washed with 
Et2O (4 x 100 mL). The layers were separated. The aqueous one was extracted with 2 x 100 mL 
of Et2O. The combined organic layers were washed with 2 x 100 mL of brine and 50 mL of 
saturated solution of NaHCO3, dried over MgSO4, filtered and the solvents removed under 
reduced pressure. The crude of the reaction was purified under silica gel chromatography (8/2 to 
1/1: Pentane/Et2O) and the alcohol (9.65 g, 79%) was obtained. Rf = 0.5 (5/5 : 
Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 4.55 (t, 3J(H,H) = 3.4 Hz, 1H); 4.17 (dt, 
3J(H,H) = 2.1, 5.9 Hz, 2H); 3.82-3.73 (m, 2H); 3.48-3.39 (m, 2H); 2.46 (t, 3J(H,H) = 5.8 Hz, 1H); 
2.8 (tt, 3J(H,H) = 5.8, 7.2 Hz, 2H); 1.74 (quint, 3J(H,H) =6.8 Hz, 2H); 1.67-1.45 (m, 6H); 13C 
NMR (75 MHz, CDCl3): δ= 98.7 (CH(O-)2); 85.4 (C≡); 78.8 (C≡); 65.8 (CH2O); 62.1 (CH2O); 
51.0 (CH2O); 30.5 (CH2); 28.6 (CH2); 25.3 (CH2); 19.4 (CH2); 15.6 (CH2). 
To a solution of the propargyl alcohol (7.5 g, 39 mmol, 1 eq), triphenylphosphine (17.2 g, 58.5 
mmol, 1.5 eq), triethylamine (0.54 mL, 3.9 mmol, 0.1 eq) in CH2Br2 (35 mL), at -10°C, was 
added a solution of CBr4 ( 19.4 g, 58.5 mmol, 1.5 eq) in CH2Br2 (35 mL). The mixture was 
stirred 3 hours at room temperature. The mixture was then quenched with 100 mL of a 10% 
solution of Na2S2O3 and 100 mL of a saturated solution of NaHCO3. The layers separated. The 
aqueous one was extracted with 3 x 250 mL of CH2Cl2 and the combined organic layers were 
extracted with Na2S2O3 (20 mL), brine (20 mL) and dried over MgSO4, filtered and the solvents 
were removed. The crude was diluted in a mixture of Pentane/Et2O 4/1 (250 mL) and filtered. 
After evaporation, the crude of the reaction was purified under silica gel chromatography (100/0 
to 80/20 pentane/Et2O) and compound (4.2 g, 41%) was obtained. Rf = 0.7 (5/5 : 
Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 4.56 (t, 3J(H,H) = 2.8 Hz, 1H); 3.88 (t, 
3J(H,H) = 2.3 Hz, 2H); 3.82-3.75 (m, 2H); 3.49-3.41 (m, 2H); 2.36-2.30 (m, 2H); 1.76 (quint, 
3J(H,H) = 6.5 Hz, 2H); 1.68-1.46 (m, 6H); 13C NMR (75 MHz, CDCl3): δ= 98.7 (CH(O-)2); 87.4 
(C≡); 75.5 (C≡); 65.7 (CH2O); 62.1 (CH2O); 30.6 (CH2); 28.5 (CH2); 25.4 (CH2); 19.4 (CH2); 
15.8 (CH2); 15.5 (CH2O). 
To the solution of protected alcohol (4.2 g, 16 mmol, 1 eq) in acetone (320 mL) was added 
dropwise at 0°C, a Jones’ solution (2.17 M, 37 mL, 80 mmol, 5.0 eq). The solution was stirred 3 
 10
hours at 0°C and 2 hours at room temperature. Isopropanol (45 mL) was slowly added. The 
mixture was filtered over Celite and rinsed with pentane/Et2O 1/1 (3 x 500 mL). The organic 
layer was washed with 4 x 250 mL of acidified brine, dried over MgSO4, filtered and the solvents 
removed under reduced pressure. The crude was diluted in anhydrous MeOH (65 mL) and 
BF3.Et2O (510 µl, 4 mmol, 0.25 eq) was added. The solution was refluxed 1H and 250 mL of a 
saturated solution of NaHCO3 was added. The mixture was extracted with 3 x 250 mL of 
pentane/Et2O 1/1. The organic layers were washed with 3 x 100 mL of brine, dried over MgSO4, 
filtered and the solvents removed. The crude of the reaction was purified under silica gel 
chromatography (95/5: Pentane/ Et2O) and 15 (2.65 g, 80%) was obtained. Rf = 0.5 (8/2 : 
Cyclohexane/AcOEt); IR (neat) : ν= 1733 (C=O); 1H NMR (300 MHz, CDCl3): δ= 3.85 (t, 
3J(H,H) = 2.1 Hz, 2H); 3.65 (s, 3H); 2.56-2.49 (m, 4H); 13C NMR (75 MHz, CDCl3): δ= 172.0 
(Cquat); 85.7 (Cquat); 76.0 (Cquat); 51.7 (CH3); 32.9 (CH2); 15.0 (CH2); 14.8 (CH2); HRMS 




At room temperature, to a solution of 13a (75 mg, 0.12 mmol, 1 eq) and 15 (44 mg, 0.21 mmol, 
1.75 eq) in DMF (4 mL) were added successively CsCO3 (120 mg, 0.28 mmol, 3 eq), NaI (55 mg, 
0.38 mmol, 3eq), CuI (58 mg, 0.31 mmol, 2.5 eq). The reaction was stirred 2 days. A solution of 
NH4Cl 10% (25 mL) and NH4OH (0.5 mL) were added. The mixture was extracted with 3 x 25 
mL of Et2O. The organic layers were washed with 2 x 25 mL of brine, dried over MgSO4, filtered 
and the solvents removed. The crude of the reaction was purified under silica gel (30nm, 
spherical) with pentane/Et2O (98/3 in presence of BHT) and 13a was obtained (46 mg, 56%) in 
presence of allene. Rf = 0.4 (8/2 : Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 5.55-
5.45 (m, 2H); 5.36-5.27 (m, 2H); 4.18 (q, 3J(H,H) = 5.9 Hz, 1H); 3.88 (dt, 3J(H,H) = 4.3, 6.9 Hz, 
1H); 3.79 (q, 3J(H,H) = 6.9 Hz, 1H); 3.67 (s, 3H); 3.06 (t, 3J(H,H) = 2 Hz, 2H); 2.64-2.53 (m, 
1H); 2.52-2.42 (m, 4H); 2.38-2.21 (m, 3H); 2.10-1.86 (m, 5H); 1.50 (dt, 3J(H,H) = 5.0 Hz, 
2J(H,H) = 13.7 Hz, 1H), 0.93 (t, 3J(H,H) = 7.5 Hz, 3H); 0.88 (s, 9H); 0.86 (s, 9H); 0.84 (s, 9H); 
0.07 (s, 3H); 0.03 (s, 3H); 0.01- -0.01 (12H); 13C NMR (75 MHz, CDCl3): δ= 173.0 (Cquat); 
1.33.0 (CH); 132.0 (CH); 129.1 (CH); 127.8 (CH); 78.3 (Cquat); 77.7 (Cquat); 76.0 (CHO-); 75.9 
(CHO-); 75.6 (Cquat); 75.5 (Cquat); 72.1 (CHO-); 52.1 (CH); 51.6 (OCH3); 50.0 (CH); 44.2 
(CH2); 33.3 (CH2); 30.3 (CH2); 28.9 (CH2); 26.0 (CH2); 25.8 (CH3); 20.6 (CH2); 18.1 (Cquat); 





In the same way, the silylated ether 16b (71 mg, 79%) was obtained with allene too. Rf = 0.4 
(8/2 : Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 5.54-5.26 (m, 4H); 4.19 (q, 3J(H,H) 
= 5.7 Hz, 1H); 3.91-3.88 (m, 1H); 3.77 (q, 3J(H,H) = 6.6 Hz, 1H); 3.67 (s, 3H); 3.07-3.02 (m, 
2H); 2.78-2.44 (m, 5H); 2.39-2.19 (m, 3H); 2.11-1.85 (m, 5H); 1.51 (dt, 3J(H,H) = 5.4 Hz, 
2J(H,H) = 13.6 Hz, 1H), 0.93 (t, 3J(H,H) = 7.4 Hz, 3H); 0.88 (s, 9H); 0.87 (s, 9H); 0.85 (s, 9H); 
0.07 (s, 3H); 0.04 (s, 3H); 0.01- -0.01 (12H); 13C NMR (75 MHz, CDCl3): δ= 173.0 (Cquat); 
134.1(CH); 132.0 (CH); 128.8 (CH); 127.8 (CH); 78.3 (Cquat); 77.7 (Cquat); 75.9 (2 x CHO-); 
75.7 (Cquat); 75.6 (Cquat); 72.0 (CHO-); 52.3 (CH); 51.6 (OCH3); 50.1 (CH); 44.2 (CH2); 33.3 
(CH2); 30.2 (CH2); 29.0 (CH2); 26.0 (CH2); 25.7 (CH3); 20.6 (CH2); 18.1 (Cquat); 17.9 (Cquat); 
14.6 (CH3); 9.6 (CH2); -4.4 (CH3); -4.6 (CH3); -4.7 (CH3); -4.8 (CH2). 
 
(S,4Z,7Z,11E)-methyl 12-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)-10-(tert-butyldimethylsilyloxy)dodeca-4,7,11-trienoate: 17a.  
To a suspension of Ni(OAc)2.4H2O (9.6 mg, 0.04 mmol, 0.33 eq), in ethanol with 0.01% BHT (3 
mL) was added under H2 atmosphere, NaBH4, in ethanol (0.5 M, 139 µL, 0.07 mmol, 0.6 eq). 
After 10 minutes was added under the black suspension, the ethylenediamine in solution in 
ethanol, (0.5 M, 348 µL, 0.17 mmol, 1.5 eq). After 10 minutes, skipped diyne 16a (85 mg, 0.12 
mmol, 1.0 eq ) in ethanol with 0.01% BHT (4 mL) was added. Before and after each addition, 
three cycles vacuum/H2 were realized. The reaction was then stirred during 4 hours under H2 
atmosphere (GC control). The mixture was then quenched with 20 mL of a saturated solution of 
NH4Cl and stirred 30 min. The layers were extracted with 3 x 25 mL of Pentane/Et2O 1/1. The 
combined organic layers were washed with water (10 mL), brine (2 x 10 mL) and dried over 
MgSO4, filtered and the solvents were removed. Compound 17a with allene, overreduction by-




enyl)cyclopentyl)-10-(tert-butyldimethylsilyloxy)dodeca-4,7,11-trienoate: 17b.  
In the same way and the same quantities, the tetraene 17b. was obtained (87 mg) with allene, 




At room temperature, a solution of HCl (0.5 M in MeOH, 2.32 mL, 1.16 mmol, 10 eq) was added 
to the crude of 17a (0.12 mmol, 1 eq) in MeOH/THF (10mL/16mL). The mixture was stirred 2 
hours and NaHCO3 solid was added. After 15 min, Celite® was added and the crude was filtered 
on Silica gel pad with AcOEt. The deprotected crude was directly used. 
The solution of crude (0.116 mmol) in THF (5.8 mL) was stirred 2 hours with LiOH (0.5 M in 
H2O, 5.8 mL, 2.4 mmol, 25 eq). The base was neutralized with a solution of NaHSO4 (1M in H2O, 
2.4 mL, 2.4 mmol, 25 eq) and NaCl solid was added. The mixture was stirred 2 hours more. The 
crude was extracted with 3 x 20 mL of AcOEt. The organic layers were washed with 2 x 10 mL 
of brine, dried over MgSO4, filtered and the solvents removed. The crude was purified by flash 
chromatography (98/2 AcOEt/HCO2H). To eliminated overreduction products and allene, the 
mixture was purified by semipreparative HPLC (250x8 mm C18 column, 2.5 mL.min-1, 
(ACN/MeOH 95/5 with 0.1% HCO2H)/H2O with 0.1% HCO2H : 35/65, λ = 205 nm), a total of 
(21.4 mg, 48%) of 10-F4t-NeuroP 1a was collected. 
Tr = 27.5 min (250x4 mm C18 Nucleodur, 0.4 mL.min-1 , (ACN/MeOH 95/5 with 0.1% 
HCO2H)/H2O with 0.1% HCO2H : 35/65, λ = 205 nm); ); [α]D20= -6 (c= 1, MeOH) ;1H NMR 
(300 MHz, MeOD): δ= 5.60-5.57 (m, 2H); 5.47-5.41 (m, 6H); 4.1 (q, 3J(H,H) = 5 Hz, 1H); 4.0 
(dt, 3J(H,H) = 2.3, 7.0 Hz, 1H); 3.91-3.87 (m, 1H); 2.87 (t, 3J(H,H) = 4.5 Hz, 2H); 2.76-2.69 (m, 
1H); 2.50 (dt, 3J(H,H) = 7.1 Hz, 2J(H,H) = 14.2 Hz, 1H); 2.44-2.29 (m, 6H); 2.16-2.04 (m, 5H); 
1.56 (dt, 3J(H,H) = 4.9 Hz, 2J(H,H) = 14.2 Hz, 1H); 0.99 (t, 3J(H,H) = 7.4 Hz, 3H); 13C NMR (75 
MHz, MeOD): δ= 177.2 (Cquat); 133.0 (CH); 130.3 (CH); 127.7 (CH); 127.2 (CH); 127.1 (CH); 
126.3 (CH); 125.8 (CH); 123.9 (CH); 73.2 (2xHCOH); 70.2 (HCOH); 50.5 (CH); 48.5(CH); 40.7 
(CH2); 33.4 (CH2); 24.2 (2xCH2); 23.8 (CH2); 21.1 (CH2); 18.7 (CH2); 11.7 (CH3); ); HRMS 
(ESI+) calculated for C22H34O5Na [M+Na]+ 401.2304, found 401.2308.. 
 
10-epi-10-F4t-NeuroP: 1b. 
In the same way and with 17b (87 mg), 10-epi-10-F4t-NeuroP 1b was obtained (35 mg; 79%). Tr 
= 30.1 min (250x4 mm C18 Nucleodur, 0.4 mL.min- , (ACN/MeOH 95/5 with 0.1% 
HCO2H)/H2O with 0.1% HCO2H : 35/65, λ = 205 nm); ); [α]D20= -8 (c= 1, MeOH); 1H NMR 
(300 MHz, MeOD): δ= 5.66-5.49 (m, 2H); 5.46-5.36 (m, 6H); 4.09 (q, 3J(H,H) = 6.0 Hz, 1H); 
4.02-3.97 (m, 1H); 3.93-3.87 (m, 1H); 2.91-2.80 (m, 2H); 2.78-2.68 (m, 1H); 2.51 (quint, 3J(H,H) 
= 7.1 Hz; 1H); 2.45-2.24 (m, 6H); 2.17-2.02 (m, 5H); 1.56 (dt, 3J(H,H) = 5.1 Hz; 2J(H,H) = 14.1 
Hz; 0.99 (t, 3J(H,H) = 7.5 Hz, 3H); 13C NMR (75 MHz, MeOD): δ= 177.2 (Cquat); 133.2(CH); 
130.2 (CH); 127.8 (2xCH); 127.1 (CH); 126.3 (CH); 125.8 (CH); 123.8 (CH); 73.4 (HCOH); 
73.3 (HCOH); 70.6 (HCOH); 50.8 (CH); 48.5(CH); 40.6 (CH2); 33.4 (CH2); 24.3 (2xCH2); 23.8 
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(CH2); 21.1 (CH2); 18.7 (CH2); 11.6 (CH3); HRMS (ESI+) calculated for C22H34O5Na [M+Na]+ 
401.2303, found 401.2304. 
 
4,5,7,8 d4-(S,4Z,7Z,11E)-methyl 12-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-
((Z)-pent-2-enyl)cyclopentyl)-10-(tert-butyldimethylsilyloxy)dodeca-4,7,11-trienoate: 18a.  
To a suspension of Ni(OAc)2.4H2O (9.6 mg, 0.04 mmol, 0.33 eq), in ethanol with 0.01% BHT (3 
mL) was added under D2 atmosphere, NaBH4, in ethanol (0.5 M, 139 µL, 0.07 mmole, 0.6 eq). 
After 10 minutes was added under the black suspension, the ethylenediamine in solution in 
ethanol, (0.5 M, 348 µL, 0.17 mmol, 1.5 eq). After 10 minutes, skipped diyne 16a (85 mg, 0.12 
mmol, 1.0 eq) in ethanol with 0.01% BHT (4 mL) was added. Before and after each addition, 
three cycles vacuum/D2 were realized. The reaction was then stirred during 4 hours under D2 
atmosphere (GC control). The mixture was then quenched with 20 mL of a saturated solution of 
NH4Cl and stirred 30 min. The layers were extracted with 3 x 25 mL of Pentane/Et2O 1/1. The 
combined organic layers were washed with water (10 mL), brine (2 x 10 mL) and dried over 
MgSO4, filtered and the solvents were removed. Compound 18a with allene, overreduction by-




((Z)-pent-2-enyl)cyclopentyl)-10-(tert-butyldimethylsilyloxy)dodeca-4,7,11-trienoate: 18b.  
In the same way and the same quantities, the tetraene 18b. was obtained (104 mg) with allene, 
overreduction by-products some solvents traces. 
 
4,5,7,8 d4-10-F4t-NeuroP: 2a. 
At room temperature, a solution of HCl (0.5 M in MeOH, 2.32 mL, 1.16 mmol, 10 eq) was added 
to the crude of 17a (0.13 mmol, 1 eq) in MeOH/THF (10 mL/16 mL). The mixture was stirred 2 
hours and NaHCO3 solid was added. After 15 min, Celite® was added and the crude was filtered 
on Silica gel pad with AcOEt. The deprotected crude was directly used. 
The solution of crude (0.12 mmol) in THF (5.8 mL) was stirred 2 hours with LiOH (0.5 M in 
H2O, 5.8 mL, 2.4 mmol, 25 eq). The base was neutralized with a solution of NaHSO4 (1 M in 
H2O, 2.4 mL, 2.4 mmol, 25 eq) and NaCl solid was added and the mixture was stirred 2 hours 
more. The crude was extracted with 3 x 20 mL of AcOEt. The organic layers were washed with 2 
x 10 mL of brine, dried over MgSO4, filtered and the solvents removed. The crude was purified 
by flash chromatography (98/2 AcOEt/HCO2H). To eliminated overreduction products and allene, 
the crude was purified by semipreparative HPLC (250x8 mm C18 column, 2.5 mL.min-1, 
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(ACN/MeOH 95/5 with 0.1% HCO2H)/H2O with 0.1% HCO2H : 35/65, λ = 205 nm), a total of 
(22.3 mg, 50%) of 4,5,7,8 d4-10-F4t-NeuroP 2a was collected. Tr = 27.0 min (250x4 mm C18 
Nucleodur, 0.4 mL.min-1 , (ACN/MeOH 95/5 with 0.1% HCO2H)/H2O with 0.1% HCO2H : 
35/65, λ = 205 nm); ); 1H NMR (300 MHz, MeOD): δ= 5.66-5.52 (m, 2H); 5.47-5.37 (m, 2H); 
4.10 (q, 3J(H,H) = 5 Hz, 1H); 4.03-3.98 (m, 1H); 3.94-3.85 (m, 1H); 2.86 (sl, 2H); 2.78-2.67 (m, 
1H); 2.50 (dt, 3J(H,H) = 7.5 Hz, 2J(H,H) = 14.2 Hz, 1H); 2.42-2.28 (m, 6H); 2.14-2.04 (m, 5H); 
1.56 (dt, 3J(H,H) = 4.8 Hz, 2J(H,H) = 14.2 Hz, 1H); 0.99 (t, 3J(H,H) = 7.4 Hz, 3H); 13C NMR (75 
MHz, MeOD): δ= 177.4 (Cquat); 133.0 (CH); 130.3 (CH); 127.1 (CH); 125.9 (CH); 73.2 
(2xHCOH); 70.2 (HCOH); 50.5 (CH); 48.5(CH); 40.7 (CH2); 33.3 (CH2); 24.2 (2xCH2); 23.5 
(CH2); 20.9 (CH2); 18.7 (CH2); 11.7 (CH3); ); HRMS (ESI+) calculated for C22H30D4O5Na 
[M+Na]+ 405.2555, found 405.2553. 
 
4,5,7,8 d4-10-epi-10-F4t-NeuroP: 2b. 
In the same way and with 2b. (87 mg), 4,5,7,8 d4-10-epi-10-F4t-NeuroP 2b was obtained (31 mg; 
70%). tr = 29.7 min (250x4 mm C18 Nucleodur, 0.4 mL.min- , (ACN/MeOH 95/5 with 0.1% 
HCO2H)/H2O with 0.1% HCO2H : 35/65, λ = 205 nm); ); 1H NMR (300 MHz, MeOD): δ= 5.63-
5.49 (m, 2H); 5.46-5.34 (m, 6H); 4.09 (q, 3J(H,H) = 6.1 Hz, 1H); 4.02-3.96 (m, 1H); 3.92-3.87 (m, 
1H); 2.86 (sl, 2H); 2.76-2.67 (m, 1H); 2.51 (dt, 3J(H,H) = 7.2 Hz; 2J(H,H) = 14.2 Hz; 1H); 2.43-
2.26 (m, 6H); 2.17-2.03 (m, 5H); 1.56 (dt, 3J(H,H) = 5.1Hz; 2J(H,H) = 14.2 Hz; 0.99 (t, 3J(H,H) = 
7.3 Hz, 3H); 13C NMR (75 MHz, MeOD): δ= 177.3 (Cquat); 133.2(CH); 130.2 (CH); 127.8 
(CH); 125.8 (CH); 73.4 (HCOH); 73.3 (HCOH); 70.6 (HCOH); 50.8 (CH); 48.5(CH); 40.6 
(CH2); 33.3 (CH2); 24.3 (2xCH2); 23.5 (CH2); 20.9 (CH2); 18.7 (CH2); 11.7 (CH3); ); HRMS 
(ESI+) calculated for C22H30D4O5Na [M+Na]+ 405.2555, found 405.2557. 
 
(E)-1-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)hept-1-en-5-yn-3-ol: 20 ; (E)-1-((1S,2R,3R,5S)-3,5-bis(tert-
butyldimethylsilyloxy)-2-((Z)-pent-2-enyl)cyclopentyl)hepta-1,4,5-trien-3-ol 19. 
To a solution of the aldehyde 9 (1.1 g, 2.45 mmol, 1 eq), in Et2O (10 mL), was added a freshly 
prepared solution of but-2-ynyl magnesium bromide (0.5 M in Et2O, 9.8 mL, 4.9 mmol, 2 eq) at 
0°C. After 40 min at the same temperature, HCl (0.1 M, 100 mL) was added and the mixture was 
stirred 15 min. The layers were separated. The aqueous layer was extracted with Et2O (3 x 50 
mL). The organic layers were washed with a saturated solution of NaHCO3 (50 mL) and brine (2 
x 50 mL), dried over MgSO4, filtered and the solvents removed. The crude of the reaction was 
purified by flash chromatography (98/2 to 95/5 Pentane/Et2O) and the propargyl alcohol 19 (161 
 15
mg, 13%) and allenic alcool 20 (550 mg, 44%) were obtained. 20 :Rf = 0.41 (9/1 : 
Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 5.53-5.49 (m, 2H); 5.34-5.28 (m, 2H); 
4.80-4.75 (m, 2H); 4.44 (sl, 1H); 3.95-3.89 (m, 1H); 3.79 (q, 3J(H,H) = 6.6 Hz, 1H); 2.69-2.60 (m, 
1H); 2.31 (dt, 3J(H,H) = 6.8 Hz, 2J(H,H) = 13.7 Hz, 1H); 2.06-1.90 (m, 5H); 1.76-1.73 (m, 1H); 
1.66 (t, 3J(H,H) = 3.0 Hz, 3H); 1.51 (dt, 3J(H,H) = 4.4 Hz, 2J(H,H) = 13.7 Hz, 1H); 0.92 (dt, 
3J(H,H) = 1.6, 7.5 Hz, 3H); 0.84 (s, 9H); 0.83 (s, 9H); 0.00- -0.02 (m, 12H); 13C NMR (75 MHz, 
CDCl3): δ= 132.3 (CH); 132.2 (CH); 132.1 (CH); 131.1 (CH); 131.0 (CH); 127.7 (CH); 77.4 
(CH); 76.5 (CH); 76.0 (HCO-); 75.8 (HCO-); 75.7 (HCO-); 73.3 (HCO-); 73.1 (HCO-); 52.4 
(CH); 52.2 (CH); 50.3 (CH); 50.2 (CH); 44.2 (CH2); 26.1 (CH2); 26.0 (CH2); 25.7 (CH3); 25.7 
(CH2); 20.6 (CH2); 17.9 (Cquat); 17.8 (Cquat); 14.6 (CH3); 14.5 (CH3); 14.1 (CH3); -4.4 (CH3); -
4.6 (CH3); -4.8 (CH); 19: Rf = 0.38 (9/1 : Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 
5.56-5.50 (m, 2H); 5.34-5.28 (m, 2H); 4.18-4.13 (m, 1H); 3.92-3.86 (m, 1H); 3.78 (q, 6.0 Hz, 
1H); 2.66-2.60 (m, 1H); 2.37-2.26 (m, 3H); 2.05-1.88 (m, 6H); 1.76 (t, 3J(H,H) = 2.5 Hz, 3H); 
1.50 (dt, 3J(H,H) = 5.1 Hz; 2J(H,H) = 13.5 Hz, 1H); 0.92 (dt, 3J(H,H) = 1.2, 7.5 Hz, 3H); 0.85 (s, 
9H); 0.84 (s, 9H); 0.02- -0.02 (m, 12H); 13C NMR (75 MHz, CDCl3): δ= 133.2 (CH); 132.0 
(CH); 131.9 (CH); 130.7 (CH); 130.6 (CH); 127.8 (CH); 78.4 (Cquat); 78.3 (Cquat); 75.7 (HCO-
); 75.7 (HCO-); 75.6 (CHO-); 74.9 (Cquat); 74.8 (Cquat); 70.8 ((HCO-); 70.7 (HCO-); 52.3 
(CH); 52.2 (CH); 50.2(CH); 44.2 (CH2); 28.0 (CH2); 26.0 (CH2); 25.7 (CH3); 20.6 (CH2); 17.9 
(Cquat); 17.8 (Cquat); 14.1 (CH3); 3.4 (CH3); -4.5 (CH3); -4.6 (CH3); -4.8 (CH3). 
 
((1R,3S,4S,5R)-4-((S,E)-3-(1-ethoxyethoxy)hept-1-en-5-ynyl)-5-((Z)-pent-2-
enyl)cyclopentane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) 21a:  
At room temperature, pyridinium p-toluene sulfonate (14 mg, 0.05 mmol, 0.015 eq) was added to 
12a (550 mg, 1.12 mmol, 1 eq) in a mixture of ethylvinyl ether/CH2Cl2 1/1 (10 mL). The reaction 
was stirred 5 hours, NaHCO3 powder (100 mg) was added, and the solution was stirred 10 min 
more. CH2Cl2 (25 mL) and saturated NaHCO3 solution (25 mL) were added. The layers were 
separated. The aqueous one was extracted with CH2Cl2 (2 x 25 mL). The organic layers were 
washed with brine (2 x 25 mL), dried over MgSO4, filtered and the solvents removed. The crude 
of the reaction was purified by flash chromatography pre-treated by Et3N (95/5 Pentane/Et2O) to 
obtain protected alkyne (487 mg, 77%). Rf = 0.53 (9/1 : Cyclohexane/AcOEt); IR (neat) : ν= 
3313 cm-1 (C≡C); 1H NMR (300 MHz, CDCl3): δ= 5.56-5.50 (m, 2H); 5.41-5.56 (m, 2H); 4.77 (q, 
3J(H,H) = 4 Hz, 0.5 H); 4.71 (q, 3J(H,H) = 0.5 H); 4.15 (q, 3J(H,H) = 5.8 Hz, 0.5 H); 4.11-4.07 (m, 
0.5H); 3.95-3.90 (m, 1H); 3.81-3.77 (m, 1H); 3.72-3.36 (m, 2H); 2.79-2.63 (m, 1H); 2.52-2.34 (m, 
2H); 2.31 (dt, 3J(H,H) = 5.3 Hz, 2J(H,H) = 10.5 Hz, 1H); 2.08-1.88 (m, 6H); 1.54-1.49 (m, 1H); 
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1.30 (d, 3J(H,H) = 4.0 Hz, 1.5H); 1.27 (d, 3J(H,H) = 4.0 Hz, 1.5H); 1.20-1.14 (m, 3H); 0.94 (t, 
3J(H,H) = 5.6 Hz, 3H); 0.86 (s, 9H); 0.85 (s, 9H); 0.01-0.00 (m, 12 H); 13C NMR (75 MHz, 
CDCl3): δ= 133.5 (CH); 132.2 (CH); 132.1 (CH), 131.8 (CH); 131.7 (CH); 130.8 (CH); 127.7 
(CH); 127.6 (CH), 98.8 (HC(O-)2); 97.1 (HC(O-)2); 81.0 (C≡); 80.9 (C≡); 75.9 (HCO-); 75.8 
(HCO-); 75.7 (HCO-); 75.0 (HCO-); 74.4 (HCO-); 70.0 (HC≡); 69.8 (HC≡); 61.1(H2CO-) ; 59.1 
(H2CO-); 52.3 (CH); 52.2 (CH); 50.2 (CH); 50.1 (CH); 44.3(CH2); 26.2 (CH2); 26.1 (CH2); 25.8 
(CH3); 20.6 (CH2); 20.4 (CH2); 20.2 (CH2); 18.0 (Cquat); 17.9 (Cquat); 15.4 (CH3); 15.2 (CH3); 
14.2 (CH3); -4.4 (CH3); -4.5 (CH3); 4.6 (CH3); -4.7 (CH3). 
At-78°C, LDA was prepared with diisopopyl amine (212 µl, 1.5 mmol, 2.3 eq) and BuLi (1.6 M 
in hexane, 900 µl, 1.44 mmol, 2.2 eq) in THF (15 mL). After 15 min, LDA was added to a 
solution of alkyne (370 mg, 0.65 mmol, 1 eq) in THF (15 mL) at -78°C. The mixture was stirred 
1 hour at the same temperature and DMPU (160 µl, 1.3 mmol, 2 eq) and MeI (61 µl, 0.98 mmol, 
1.5 eq) was added. The reaction was stirred overnight. Brine (25 mL) with Na2CO3 solution (2.5 
mL) was added. The mixture was extracted with Et2O (3 x 20 mL). The organic one were washed 
with brine (2 x 10 mL), dried over MgSO4, filtered and the solvents removed. The crude of the 
reaction was purified by flash chromatography pre-treated by Et3N (95/5 Pentane/Et2O) to obtain 
21a (269 mg, 71%). Rf = 0.5 (9/1 : Cyclohexane/AcOEt); 1H NMR (400 MHz, CDCl3): δ= 5.52-
5.47 (m, 2H); 5.40-5.30 (m, 2H); 4.78-4.75 (m, 0.5H); 4.72-4.70 (m, 0.5H); 4.17-4.01 (m, 1H); 
3.95-3.89 (m, 1H); 3.81-3.76 (m, 1H); 3.72-3.65 (m, 0.5H); 3.62-3.52 (m, 1H); 3.43-3.67 (m, 
0.5H); 2.69-2.63 (m, 1H); 2.53-2.29 (m, 4H); 2.09-1.85 (m, 5H); 1.74-1.73 (m, 3H); 1.53-1.47 (m, 
1H); 1.31-1.14 (m, 6H); 0.94 t, 3J(H,H) = 7.5 Hz, 3H); 0.86 (s, 9H); 0.85 (s, 9H); 0.01 (s, 6H); 
0.00 (s, 6H); 13C NMR (100 MHz, CDCl3): δ= 133.5 (CH); 132.2 (CH); 132.1 (CH); 131.8 (CH); 
131.7 (CH); 130.9 (CH); 127.8 (CH); 127.7 (CH); 98.9 (HC(O-)2); 97.1 (HC(O-)2); 81.0 (C≡); 
80.9 (C≡); 76.0 (HCO-); 75.9 (HCO-); 75.8 (HCO-); 75.7 (C≡); 75.6 (C≡); 70.0 (HCO-); 69.8 
(HCO-); 59.1 (H2CO-); 59.0 (H2CO-); 52.3 (CH); 52.2 (CH); 50.2 (CH); 50.1 (CH); 44.3 (CH2); 
26.5 (CH2); 26.4 (CH2); 26.6 (CH2); 25.8 (CH3); 20.6 (CH2); 20.5 (CH2); 18.0 (Cquat); 17.9 
(Cquat); 15.4 (CH3); 15.2 (CH3); 14.2 (CH3); 14.0 (CH3); 3.5 (CH3); -4.4 (CH3); -4.5 (CH3). 
 
((1R,3S,4S,5R)-4-((R,E)-3-(1-ethoxyethoxy)hept-1-en-5-ynyl)-5-((Z)-pent-2-
enyl)cyclopentane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) 21b : 
In the same way, with the other diastereoisomer 12b (665 mg, 1.35 mmol, 1 eq), the protected 
alkyne was obtained (672 mg, 88%). Rf = 0.53 (9/1 : Cyclohexane/AcOEt); IR (neat) : ν= 3313 
cm-1 (C≡C); 1H NMR (300 MHz, CDCl3): δ= 5.56-5.47 (m, 2H); 5.45-5.27 (m, 2H); 4.80-4.70 
(m,1H); 4.18-4.08 (m, 1H); 3.96-3.90 (m, 1H); 3.81-3.75 (m, 1H); 3.73-3.32 (m, 2H); 2.68-2.62 
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(m, 1H); 2.52-2.29 (m, 3H); 2.10-1.85 (m, 6H); 1.56-1.49 (m, 1H); 1.31-1.26 (m, 3H); 1.31-1.26 
(m, 3H); 1.21-1.15 (m, 4H); 0.93 (t, 3J(H,H) = 5.6 Hz, 3H); 0.86 (s, 9H); 0.85 (s, 9H); 0.01-0.00 
(m, 12 H); 13C NMR (75 MHz, CDCl3): δ= 133.3 (CH); 132.1 (CH); 132.0 (CH), 131.8 (CH); 
131.5 (CH); 131.0 (CH); 127.8 (CH); 127.7 (CH), 98.8 (HC(O-)2); 97.1 (HC(O-)2); 80.9 (C≡); 
80.8 (C≡); 76.0 (HCO-); 75.9 (HCO-); 75.8 (HCO-); 75.7 (HCO-); 75.0 (HCO-); 74.2 (HCO-); 
70.0 (HC≡); 69.8 (HC≡); 61.2(H2CO-); 59.0 (H2CO-); 52.5 (CH); 50.2 (CH); 50.3 (CH); 
44.3(CH2); 26.2 (CH2); 26.0 (CH2); 25.8 (CH3); 20.6 (CH2); 20.5 (CH2); 20.2 (CH2); 18.0 
(Cquat); 15.4 (CH3); 15.2 (CH3); 14.2 (CH3); -4.4 (CH3); -4.5 (CH3). 
In the same way, the other diastereoisomer (660 mg, 1.17 mmol, 1 eq), 21b was obtained (481 
mg, 87%). Rf = 0.5 (9/1 : Cyclohexane/AcOEt); 1H NMR (400 MHz, CDCl3): δ= 5.54-5.41 (m, 
2H); 5.38-5.31 (m, 2H); 4.76-4.71 (m, 1H); 4.11-4.01 (m, 1H); 3.96-3.88 (m, 1H); 3.80-3.76 (m, 
1H); 3.71-3.28 (m, 2H); 2.67-2.59 (m, 1H); 2.52-2.26 (m, 4H); 2.10-1.85 (m, 5H); 1.72 (sl, 3H); 
1.54-1.49 (m, 1H); 1.30-1.15 (m, 6H); 0.93 t, 3J(H,H) = 7.5 Hz, 3H); 0.86 (s, 9H); 0.84 (s, 9H); 
0.01- -0.01(m, 12H); 13C NMR (100 MHz, CDCl3): δ= 132.9 (CH); 132.3 (CH); 132.1 (CH); 
131.6 (CH); 131.1 (CH); 127.8 (CH); 127.7 (CH); 98.8 (HC(O-)2); 97.1 (HC(O-)2); 77.2 (C≡); 
77.0 (C≡); 76.1 (HCO-); 76.0 (HCO-); 75.9 (HCO-); 75.8 (C≡); 75.7 (C≡); 75.6 (HCO-); 75.0 
(HCO-); 61.1 (H2CO-); 58.9 (H2CO-); 52.6 (CH); 52.5 (CH); 50.4 (CH); 44.4 (CH2); 44.3 (CH2); 
26.6 (CH2); 26.5 (CH2); 26.1 (CH2); 26.0 (CH2); 25.8 (CH3); 20.6 (CH2); 20.5 (CH2); 18.0 
(Cquat); 17.9 (Cquat); 15.4 (CH3); 15.2 (CH3); 14.2 (CH3); 13.9 (CH3); 3.5 (CH3); -4.4 (CH3); -
4.5 (CH3); -4.6 (CH3); -4.8 (CH3). 
(S,E)-1-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)hept-1-en-5-yn-3-ol 19a : 
At room temperature, 21a (232 mg, 0.4 mmol, 1 eq), and pyridinium p-toluene sulfonate (50 mg, 
0.2 mmol, 0.5 eq) in a solution of propanol/CH2Cl2 6/1 (26 mL) were stirred 4 hours. NaHCO3 
powder was added, the solvent were removed and the crude was purified by flash 
chromatography (95/5 to 90/10 Pentane/Et2O) to obtain 19a (145 mg, 71%). Rf = 0.26 (9/1 : 
Cyclohexane/AcOEt); [α]D20= -16.5 (c= 10, CHCl3) ; IR (neat) : ν= 3360 cm-1 (OH); 1H NMR 
(400 MHz, CDCl3): δ= 5.62-5.52 (m, 2H); 5.42-5.29 (m, 2H); 4.23-4.18 (m, 1H); 3.92 (dt, 
3J(H,H) = 5.0, 7.1 Hz, 1H); 3.95-3.80 (m, 1H); 3.70-3.65 (m, 1H); 2.47-2.30 (m, 3H); 2.12-1.91 
(m, 6H); 1.80 (t, 4J(H,H) = 2.5 Hz, 3H); 1.54 (dt, 3J(H,H) = 5.3 Hz, 2J(H,H) = 13.7 Hz, 1H); 0.96 
(t, 3J(H,H) = 7.6 Hz, 3H); 0.89 (s, 9H); 0.87 (s, 9H); 0.04-0.02 (m, 12H); NMR (100 MHz, 
CDCl3): δ= 133.2 (CH); 132.1 (CH); 130.8 (CH); 127.8 (CH); 78.5 (C≡); 76.0 (HCO-); 75.7 
(C≡); 74.8 (HCO-); 70.8 (HCO-); 52.2 (CH); 50.3 (CH); 44.3 (CH2); 28.1 (CH2); 26.1 (CH2); 
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25.8 (CH3); 20.7 (CH2); 18.0 (Cquat); 17.9 (Cquat); 14.2 (CH3); 3.5 (CH3); -4.4 (CH3); -4.6 
(CH3); -4.8 (CH3); HRMS (ESI+) calculated for C29H55O3Si2 [M+H]+ 507.3690, found 507.3684. 
(R,E)-1-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)hept-1-en-5-yn-3-ol 19b : 
In the same way, with 21b (480 mg, 0.83 mmol, 1 eq), deprotected alcohol 19b was obtain (241 
mg, 57%). Rf = 0.26 (9/1 : Cyclohexane/AcOEt); [α]D20= -6.9 (c= 10, CHCl3); IR (neat) : ν= 3360 
cm-1 (OH); 1H NMR (400 MHz, CDCl3): δ= 5.61-5.49 (m, 2H); 5.39-5.30 (m, 2H); 4.20 (q, 
3J(H,H) = 5.8 Hz; 1H); 3.94 (dt, 3J(H,H) = 4.7, 7.0 Hz, 1H); 3.84-3.79 (m, 1H); 3.68-3.63 (m, 
1H); 2.45-2.30 (m, 3H); 2.11-1.88 (m, 6H); 1.80 (t, 4J(H,H) = 2.5 Hz, 3H); 1.54 (dt, 3J(H,H) = 5.2 
Hz, 2J(H,H) = 13.7 Hz, 1H); 0.96 (t, 3J(H,H) = 7.5 Hz, 3H); 0.88 (s, 9H); 0.87 (s, 9H); 0.04-0.02 
(m, 12H); NMR (100 MHz, CDCl3): δ= 133.2 (CH); 132.1 (CH); 130.7 (CH); 127.8 (CH); 78.4 
(C≡); 76.0 (HCO-); 75.8 (C≡); 74.9 (HCO-); 70.9 (HCO-); 52.4 (CH); 50.3 (CH); 44.2 (CH2); 
28.1 (CH2); 26.1 (CH2); 25.8 (CH3); 20.6 (CH2); 18.0 (Cquat); 17.9 (Cquat); 14.2 (CH3); 3.5 
(CH3); -4.4 (CH3); -4.6 (CH3); -4.7 (CH3); -4.8 (CH3); HRMS (ESI+) calculated for C29H55O3Si2 
[M+H]+ 507.3690, found 507.3685. 
4-hydroxybutyl hept-5-ynoate : 23. 
At-78°C, LDA was prepared with diisopopylamine (8.65 mL, 61.5 mmol, 2.3 eq) and BuLi (1.6 
M in hexane, 36.7 mL, 58.8 mmol, 2.2 eq) in THF (250 mL). After 15 min, LDA was added to a 
solution of 5-hexynoïc acid (3 g, 26.7 mmol, 1 eq) at -78°C. The mixture was stirred 1 hour at the 
same temperature and DMPU (6.47 mL, 53.5 mmol, 2 eq) and MeI (2.5 mL, 40.1 mmol, 1.5 eq) 
was added. The reaction was stirred overnight. A solution of HCl 1M (150 mL) was added and 
saturated with NaCl powder. The mixture was extracted with Et2O (3 x 200 mL). The organic one 
were washed with brine (2 x 150 mL), dried over MgSO4, filtered and the solvents removed. The 
crude of the reaction was purified by flash chromatography (69/29/2 Pentane/Et2O/HCO2H) to 
obtain hept-5-ynoic acid (3.27 g, 97%). Rf = 0.45 (1/1 : Cyclohexane/AcOEt); 1H NMR (300 
MHz, CDCl3): δ= 10.6 (ls, 1H); 2.46 (t, 3J(H,H) = 7.4 Hz, 2H); 2.27-2.15 (m, 2H); 1.86-1.73 (m, 
5H); NMR (75 MHz, CDCl3): δ= 179.6 (C=O); 77.6 (C≡); 76.3 (C≡); 32.7 (CH2); 23.8 (CH2); 
18.0 (CH2); 3.3 (CH3). 
Hept-5-ynoic acid (3g, 23.7 mmol, 1 eq), 1,4 butan-diol (10.5 mL, 119 mmol, 5 eq) and p-
toluenesulfonyl acid (113 mg, 0.6 mmol, 0.025 eq) in heptane (250 mL) were refluxed 1 hour 
with Dean-Stark apparatus. The reaction was cooled and brine (200 mL) was added. The layers 
were separated. The aqueous one was extracted with 3 x 200 mL of Et2O. The organic layers 
were washed with brine (3 x 100 mL), dried over MgSO4, filtered and the solvents removed. The 
crude of the reaction was purified by flash chromatography (8/2 to 4/6 Pentane/Et2O) to obtain 23 
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(4.3 g, 91%). Rf = 0.27 (1/1: Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 4.07 (t, 
3J(H,H) = 6.3 Hz, 2H); 3.63 (t, 3J(H,H) = 6.3 Hz, 2H); 2.38 (t, 3J(H,H) = 7.4 Hz, 2H); 2.11-2.18 
(m, 2H); 1.77-1.59 (m, 10H); NMR (75 MHz, CDCl3): δ= 173.3 (C=O); 77.8 (C≡); 76.3 (C≡); 
64.1 (H2CO-); 62.2 (H2CO-); 33.1 (CH2); 29.0 (CH2); 25.0 (CH2); 24.1 (CH2); 18.1 (CH2); 3.3 
(CH3). 
4-(hept-5-ynoyloxy)butanoic acid: 22. 
At -60°C, DMSO (3.84 mL, 54.2 mmol, 2.5 eq) was added to a solution of oxalyl chloride (2.35 
mL, 27.1 mmol, 1.25 eq) in CH2Cl2 (150 mL). The reaction was stirred 10 min and 23 (4.3 g, 
21.7 mmol, 1eq) diluted in CH2Cl2 (45 mL) was added. After 10 min more, Et3N (16.6 mL, 119.3 
mmol, 5.5 eq) was added. The reaction mixture was allowed to reach 0°C. Brine (100 mL) and 
water (100 mL) were added. The layers were separated. The aqueous one was extracted with 3 x 
200 mL of CH2Cl2. The organic layers were washed with brine (3 x 100 mL), dried over MgSO4, 
filtered and the solvents removed. The crude of the reaction was purified by flash 
chromatography (9/1 to 7/3 Pentane/Et2O) to obtain 4-oxobutyl hept-5-ynoate (4.19 g, 98%). Rf = 
0.24 (3/1: Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 9.72 (ls, 1H); 4.04 (t, 3J(H,H) =, 
6.3 Hz, 2H); 2.47 (t, 3J(H,H) = 7.2 Hz, 2H); 2.34 (t, 3J(H,H) = 7.4 Hz, 2H); 2.09-2.16 (m, 2H); 
1.90 (quint, 3J(H,H) = 7.0 Hz, 2H); 1.73-1.68 (m, 5H); NMR (75 MHz, CDCl3): δ= 200.9 (C=O); 
173.0 (C=O); 77.7 (C≡); 76.3 (C≡); 63.1 (H2CO-); 40.3 (CH2); 32.9 (CH2); 24.0 (CH2); 21.3 
(CH2); 18.1 (CH2); 3.3 (CH3). 
At room temperature, Sodium Chlorite (2.11 g, 23.3 mmol, 1.1 eq) was added by portion to a 
solution of aldehyde (4.19 g, 21.3 mmol, 1 eq), 2 methyl butene (3.48 mL, 32.9 mmol, 1.5 eq), 
KH2PO4 (450 mg, 3.29 mmol, 0.15 eq) in a mixture of H2O/tBuOH 1/4 (40 mL). The mixture was 
stirred 1 hour and was acidified to pH = 1 with a solution of HCl 1M. The solution was extracted 
with 3 x 100 mL of CH2Cl2. The organic layer was washed with 2 x 100 mL of brine, dried over 
MgSO4, filtered and the solvents removed. The crude of the reaction was purified by flash 
chromatography (3/1 to 1/1 Pentane/Et2O) to obtain 22 (3.6 g, 78 %). Rf = 0.3 (1/1: 
Cyclohexane/AcOEt); 1H NMR (300 MHz, CDCl3): δ= 4.09 (t, 3J(H,H) = 6.3 Hz, 2H); 2.44-2.36 
(m, 4H); 2.17-2.11 (m, 2H); 1.94 (quint, 3J(H,H) = 6.7 Hz, 2H); 1.78-1.69 (m, 5H); NMR (75 
MHz, CDCl3): δ= 178.8 (C=O); 173.2 (C=O); 77.7 (C≡); 76.4 (C≡); 63.1 (H2CO-); 32.9 (CH2); 
30.4 (CH2); 24.0 (CH2); 23.7 (CH2); 18.1 (CH2); 3.3 (CH3). 
4-((S,E)-1-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)hept-1-en-5-yn-3-yloxy)-4-oxobutyl hept-5-ynoate: 24a . 
At room temperature, alcohol 19a (145 mg, 0.28 mmol, 1 eq), acid 22 (121 mg, 0.57 mmol, 2 eq), 
EDCI (109 mg, 0.57 mmol, 2 eq), DMAP (14 mg, 0.114 mmol, 0.4 eq) in CH2Cl2 (10 mL) were 
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stirred overnight. Brine (10 mL) and water (5 mL) were added. The reaction mixture was 
extracted with 3 x 20 mL of Et2O. The organic layers were washed with 3 x 10 mL of brine, dried 
over MgSO4, filtered and the solvents removed. The crude of the reaction was purified by flash 
chromatography (97/3 Pentane/Et2O) to obtain 24a (191 mg, 95 %). Rf = 0.34 (9/1: 
Cyclohexane/AcOEt); [α]D20= -17.6 (c= 10, CHCl3); IR (neat) : ν= 1737 cm-1 (C=O); 1H NMR 
(400 MHz, CDCl3): δ= 5.63 (dd, 3J(H,H) = 9.2, 15.4 Hz, 1H); 5.54 (dd, 3J(H,H) = 6.9, 15.4 Hz, 
1H); 5.39-5.30 (m, 3H); 4.11 (t, 3J(H,H) = 6.4 Hz, 2H); 3.95-3.89 (m, 1H); 3.81 (q, 3J(H,H) = 5.8 
Hz, 1H); 2.70-2.64 (m, 1H); 2.46-2.17 (m, 7H); 2.21-2.17 (m, 2H); 2.08-1.85 (m, 8H); 1.83-1.75 
(m, 7H); 1.54 (dt, 3J(H,H) = 5.3 Hz, 2J(H,H) = 13.6 Hz, 1H); 0.95 (t, 3J(H,H) = 7.5 Hz, 3H), 0.88 
(s, 9H); 0.86 (s, 9H); 0.03-0.01 (m, 12H); NMR (100 MHz, CDCl3): δ= 173.2 (C=O); 171.8 
(C=O); 134.1 (CH); 132.2 (CH); 128.8 ; (CH) 127.7 (CH); 77.9 (C≡); 77.8 (C≡); 76.4 (C≡); 75.8 
(C≡); 75.6 (HCO-); 74.2 (HCO-); 73.0 (HCO-); 63.3 (H2CO-); 52.2 (CH); 50.4 (CH); 44.3 (CH2); 
33.1 (CH2); 31.0 (CH2); 26.0 (CH2); 25.8 (CH3); 25.1 (CH2); 24.2 (CH2); 24.1 (CH2); 20.6 (CH2); 
18.2 (CH2); 18.0 (Cquat); 17.9 (Cquat); 14.2 (CH3); 3.5 (CH3); 3.4 (CH3); -4.4 (CH3); -4.5 (CH3); 
-4.6 (CH3); -4.7 (CH3); HRMS (ESI+) calculated for C40H69O6Si2 [M+H]+ 701.4633, found 
701.4632. 
4-((R,E)-1-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyloxy)-2-((Z)-pent-2-
enyl)cyclopentyl)hept-1-en-5-yn-3-yloxy)-4-oxobutyl hept-5-ynoate: 24a . 
In the same way and with 19b. (166 mg), 24b was obtained (174 mg; 76%). Rf = 0.34 (9/1: 
Cyclohexane/AcOEt); [α]D20= +3.0 (c= 10, CHCl3); IR (neat) : ν= 1739 cm-1 (C=O); 1H NMR 
(400 MHz, CDCl3): δ= 5.58 (dd, 3J(H,H) = 9.4, 15.3 Hz, 1H); 5.48 (dd, 3J(H,H) = 7.1, 15.3 Hz, 
1H); 5.35-5.25 (m, 3H); 4.09 (t, 3J(H,H) = 6.4 Hz, 2H); 3.91-3.86 (m, 1H); 3.76 (q, 3J(H,H) = 6.4 
Hz, 1H); 2.66-2.60 (m, 1H); 2.44-2.22 (m, 7H); 2.19-2.14 (m, 2H); 2.02-1.82 (m, 8H); 1.80-1.71 
(m, 7H); 1.51 (dt, 3J(H,H) = 5.2 Hz, 2J(H,H) = 13.6 Hz, 1H); 0.93 (t, 3J(H,H) = 7.5 Hz, 3H), 0.85 
(s, 9H); 0.83 (s, 9H); 0.00 (s, 6H); -0.02 (s, 3H); -0.03 (s, 3H); NMR (100 MHz, CDCl3): δ= 
173.2 (C=O); 171.7 (C=O); 134.1 (CH); 132.2 (CH); 128.9 (CH); 127.7 (CH); 77.9 (2 x C≡); 
76.4 (C≡); 75.8 (C≡); 75.6 (HCO-); 74.2 (HCO-); 73.1 (HCO-); 63.3 (H2CO-); 52.4 (CH); 50.5 
(CH); 44.3 (CH2); 33.1 (CH2); 31.0 (CH2); 26.0 (CH2); 25.8 (CH3); 25.6 (CH2); 24.2 (CH2); 24.1 
(CH2); 20.6 (CH2); 18.2 (CH2); 18.0 (Cquat); 17.9 (Cquat); 14.2 (CH3); 3.4 (2 x CH3); -4.4 
(CH3); -4.6 (CH3); -4.7 (CH3); -4.8 (CH3). HRMS (ESI+) calculated for C40H69O6Si2 [M+H]+ 




MnCl2 was dried under vacuum at 150°C overnight, 5 Ǻ molecular sieves powder was dried 
under vacuum at 400 °C during 30 min. 24Fehler! Verweisquelle konnte nicht gefunden 
werden.a was dried by azeotropic evaporation with toluene. 
Catalyst 25Fehler! Verweisquelle konnte nicht gefunden werden. (50 mg, 0.04 mmol, 15% mol), 
MnCl2 (10.3 mg, 0.08 mmol, 30% mol) and molecular sieves powder (5 Ǻ, 1 g) in toluene (5 mL) 
were heated at 80°C during 30 min. 24Fehler! Verweisquelle konnte nicht gefunden werden.a 
(191 mg, 0.27 mmol, 1 eq) in toluene (10 mL) was added and the resulting reaction mixture 
heated 6 hours at 80°C and stirred overnight at room temperature. For work up, the molecular 
sieves were filtered off through a short pad of silica, the filtrate was evaporated and the residue 
purified by flash chromatography (97/3 to 90/10, pentane/Et2O) to obtain Fehler! Verweisquelle 
konnte nicht gefunden werden.a colorless syrup 26a (126 mg, 69 % with traces of silanol 
impurities). Rf  = 0.21 (9/1: cyclohexane/AcOEt); 1H NMR (400 MHz, CDCl3): δ = 5.64 (dd, 
3J(H,H) = 9.5, 14.8 Hz, 1H); 5.49-5.28 (m, 4H); 4.19-4.07 (m, 2H); 3.91-3.87 (m, 1H); 3.83-3.78 
(m, 1H); 2.68-2.57 (m, 2H); 2.47-2.24 (m, 9H); 2.06-1.81 (m, 7H); 1.74-1.65 (m, 1H); 1.53 (dt, 
3J(H,H) = 5.5 Hz, 2J(H,H) = 13.6 Hz, 1H); 0.96 (t, 3J(H,H) = 7.5 Hz, 3H); 0.88 (s, 9H); 0.86 (s, 
9H); 0.03 (s, 6H); 0.01 (s, 3H); 0.00 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 173.3 (C=O); 
172.2 (C=O); 134.3 (CH); 132.2 (CH); 129.2 ; (CH) 127.7 (CH); 79.8 (C≡); 78.0 (C≡); 75.8 
(HCO-); 75.5 (HCO-); 73.3 (HCO-); 63.9 (H2CO-); 52.2 (CH); 50.6 (CH); 44.2 (CH2); 31.9 
(CH2); 31.6 (CH2); 26.0 (CH2); 25.8 (CH3); 25.1 (CH2); 23.3 (CH2); 22.1 (CH2); 20.6 (CH2); 18.0 
(CH2); 17.9 (Cquat); 17.6 (Cquat); 14.2 (CH3); -4.4 (CH3); -4.5 (CH3); -4.6 (CH3); -4.7 (CH3); 
HRMS (ESI+) calculated for C36H63O6Si2 [M+H]+ 647.4163, found 647.4154. 
 (R,E)-10-((1S,2R,3R,5S)-3,5-bis(tert-butyldimethylsilyl)-2-((Z)-pent-2-enyl)cyclopentyl)-8-
(4-hydroxybutanoyloxy)dec-9-en-5-ynoate: 26b. 
Prepared analogously from 24Fehler! Verweisquelle konnte nicht gefunden werden.b (174 mg); 
product 26Fehler! Verweisquelle konnte nicht gefunden werden.b was obtained as a colorless 
syrup (110 mg; 66%). Rf  = 0.21 (9/1: cyclohexane/AcOEt); 1H NMR (400 MHz, CDCl3): δ = 
5.61 (dd, 3J(H,H) = 9.6, 14.5 Hz, 1H); 5.47-5.25 (m, 4H); 4.19-4.06 (m, 2H); 3.92-3.87 (m, 1H); 
3.80-3.76 (m, 1H); 2.62-2.55 (m, 2H); 2.44-2.18 (m, 9H); 2.05-1.80 (m, 7H); 1.74-1.65 (m, 1H); 
1.52 (dt, 3J(H,H) = 5.5 Hz, 2J(H,H) = 13.6 Hz, 1H); 0.95 (t, 3J(H,H) =  7.5 Hz, 3H); 0.87 (s, 9H); 
0.85 (s, 9H); 0.02 (s, 6H); 0.00 (s, 3H); -0.01 (s, 3H); NMR (100 MHz, CDCl3): δ = 173.3 
(C=O); 172.2 (C=O); 134.0 (CH); 132.3 (CH); 129.3 (CH); 127.6 (CH); 79.8 (C≡); 78.0 (C≡); 
75.7 (HCO-); 75.5 (HCO-); 73.2 (HCO-); 63.8 (H2CO-); 52.3 (CH); 50.5 (CH); 44.2 (CH2); 32.0 
(CH2); 31.7 (CH2); 26.1 (CH2); 25.8 (CH3); 25.2 (CH2); 23.3 (CH2); 22.2 (CH2); 20.7 (CH2); 18.0 
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(CH2); 17.9 (2 x Cquat); 14.2 (CH3); -4.4 (CH3); -4.6 (2 x CH3); -4.7 (CH3); HRMS (ESI+) 
calculated for C36H63O6Si2 [M+H]+ 647.4163, found 647.4146. 
8-F3t-IsoP: 3a. 
To a suspension of Ni(OAc)2.4H2O (23.5 mg, 0.09 mmol, 0.5 eq), in ethanol with 0.01% BHT (5 
mL) was added under H2 atmosphere, NaBH4, in ethanol (0.5 M, 339 µL, 0.17 mmol, 0.9 eq). 
After 10 minutes was added under the black suspension, the ethylenediamine in solution in 
ethanol, (0.5 M, 1.7 mL, 0.85 mmol, 4.5 eq). After 10 minutes, 26a (126 mg, 0.19 mmol, 1.0 eq ) 
in ethanol with 0.01% BHT (10 mL) was added. Before and after each addition, three cycles 
vacuum/H2 were realized. The reaction was then stirred during 48 hours under H2 atmosphere 
(GC control). The mixture was then quenched with 20 mL of a saturated solution of NH4Cl and 
stirred 30 min. The layers were extracted with 3 x 20 mL of Et2O. The combined organic layers 
were washed with brine (3 x 10 mL) and dried over MgSO4, filtered and the solvents were 
removed. The crude of the reaction was purified by flash chromatography (97/3 Pentane/Et2O) to 
obtain ethylenic compound (88.3 mg, 70 %). Rf = 0.29 (9/1: Cyclohexane/AcOEt); [α]D20= -50.5 
(c= 10, CHCl3); ν= 1737 cm-1 (C=O); 1H NMR (400 MHz, CDCl3): δ= 5.58-5.56 (m, 2H); 5.45-
5.27 (m, 5H); 4.20 (dt, 3J(H,H) = 4.4; 2J(H,H) = 11 Hz, 1H); 4.03 (dt, 3J(H,H) = 3.6; 2J(H,H) = 11 
Hz; 1H); 3.93-3.89 (m, 1H); 3.81 (q, 3J(H,H) = 5.6 Hz; 1H); 2.69-2.65 (m, 1H); 2.54 (ddd, 
3J(H,H) = 4.4, 11.3, 15.6 Hz, 1H); 2.48-2.25 (m, 6H); 2.12-1.88 (m, 9H); 1.79 (quint, 3J(H,H) = 
5.6 Hz, 1H); 1.54 (dt, 3J(H,H) = 5.5 Hz, 2J(H,H) = 13.7 Hz, 1H); 0.96 (t, 3J(H,H) = 7.6 Hz, 3H); 
0.88 (s, 9H); 0.86 (s, 9H); 0.03 (s, 6H); 0.02 (s, 3H); 0.01 (s, 3H); NMR (100 MHz, CDCl3): δ= 
173.7 (C=O); 172.0 (C=O); 132.8 (CH); 132.2 (CH); 131.8 (CH); 129.6 ; (CH) 127.7 (CH); 
124.8 (CH); 75.9 (HCO-); 75.5 (HCO-); 73.7 (HCO-); 62.1 (H2CO-); 52.4 (CH); 50.5 (CH); 44.2 
(CH2); 33.7 (CH2); 32.8 (CH2); 30.3 (CH2); 26.4 (CH2); 26.1 (CH2); 25.8 (CH3); 24.9 (CH2); 23.3 
(CH2); 20.6 (CH2); 18.0 (Cquat); 17.9 (Cquat); 14.2 (CH3); -4.4 (CH3); -4.5 (CH3); -4.6 (CH3); -
4.7 (CH3); HRMS (ESI+) calculated for C36H65O6Si2 [M+H]+ 649.4320, found 649.4333. 
At room temperature, a HCl solution (0.5 M in MeOH, 2.46 mL, 1.23 mmol, 10 eq) was added to 
a solution of protected compound (83 mg, 0.12 mmol, 1 eq) in THF/MeOH (17 mL/9 mL). The 
reaction was stirred 2 hours and NaHCO3 powder was added. After 5 min of agitation, celite® 
was added and the solvent were evaporated. The crude of the reaction was purified by flash 
chromatography (95/5 to 90/10 Pentane/Et2O) to obtain free hydroxyl compound (44 mg, 84 %). 
Rf = 0.3 (AcOEt); [α]D20= -51.9 (c= 10, CHCl3); ν= 3389 (OH); 1732 cm-1 (C=O); 1H NMR (400 
MHz, CDCl3): δ= 5.61 (dd, 3J(H,H) = 6.4 Hz, 2J(H,H) = 16 Hz, 1H); 5.53 (dd, 3J(H,H) = 8.8 Hz, 
2J(H,H) = 16 Hz, 1H); 5.45-5.31 (m, 5H); 4.19 (dt, 3J(H,H) = 3.6; 2J(H,H) = 11.2 Hz, 1H); 4.07-
3.95 (m, 3H); 2.81-2.76 (m, 1H); 2.54 (ddd, 3J(H,H) = 4.5, 11.1, 15.5 Hz, 1H); 2.46-2.37 (m, 
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4H); 3.31-2.24 (m, 2H); 2.21-2.16 (m, 1H); 2.12-1.90 (m, 8H); 1.78 (quint, 3J(H,H) = 6.7 Hz, 
2H); 1.66 (dt, 3J(H,H) = 3.6 Hz, 2J(H,H) = 14.4 Hz, 1H); 0.96 (t, 3J(H,H) = 7.5 Hz, 3H); NMR 
(100 MHz, CDCl3): δ= 173.7 (C=O); 172.2 (C=O); 133.1 (CH); 132.0 (CH); 131.2 (CH); 130.5 ; 
(CH) 127.2 (CH); 124.6 (CH); 76.4 (HCOH); 76.2 (HCOH); 73.6 (HCO-); 62.2 (H2CO-); 53.6 
(CH); 50.9 (CH); 42.3 (CH2); 33.6 (CH2); 32.8 (CH2); 30.4 (CH2); 26.9 (CH2); 26.4 (CH2); 24.7 
(CH3); 23.4 (CH2); 20.7 (CH2); 14.2 (CH3); HRMS (ESI+) calculated for C24H37O6 [M+H]+ 
421.2590, found 421.2588. 
At room temperature, a solution of LiOH (0.5 M, 5 mL, 2.5 mmol, 25 eq) was added to a solution 
of lactone (44 mg, 0.1 mmol, 1 eq) in THF (5 mL). The reaction was stirred 4 hours and was 
acidified with a solution of NaHSO4 (1M) until pH = 2. The mixture was extracted with 3 x 20 
mL of AcOEt. The combined organic layers were washed with brine (2 x 10 mL) and dried over 
MgSO4, filtered and the solvents were removed. The crude of the reaction was purified by flash 
chromatography (100/0 to 98/2 AcOEt/HCO2H) to obtain 3a (34.8 mg, 94 %). Rf = 0.27 
(AcOEt/HCO2H 95/5); [α]D20= -8.0 (c= 5, MeOH); 1H NMR (300 MHz, MeOD): δ= 5.59-5.57 
(m, 2H); 5.51-5.45 (m, 2H); 5.43-5.40 (m, 2H); 4.09 (q, 3J(H,H) = 6.4 Hz, 1H); 4.03-3.97 (m, 
1H); 3.91-3.87 (m, 1H); 2.74-2.69 (m, 1H); 2.50 (dt, 3J(H,H) = 7.4 Hz, 2J(H,H) = 14.2 Hz, 1H); 
2.35-2.29 (m, 4H); 2.17-2.06 (m, 7H); 1.69 (quint, 3J(H,H) = 7.3 Hz, 1H); 1.56 (dt, 3J(H,H) = 4.9 
Hz, 2J(H,H) = 14.2 Hz, 1H); 0.99 (t, 3J(H,H) = 7.5 Hz, 3H); NMR (75 MHz, MeOD): δ= 175.0 
(C=O); 133.0 (CH); 130.3 (CH); 128.7 (CH); 127.2 (CH); 125.8 (CH); 124.5 (CH); 73.2 (2 x 
HCOH); 70.3 (HCOH); 50.5 (CH); 48.5 (CH); 40.6 (CH2); 33.4 (CH2); 31.7 (CH2); 24.7 (CH3); 
24.2 (CH2); 23.1 (CH2); 18.7 (CH2); 11.7 (CH3); HRMS (ESI+) calculated for C20H32O5 [M+Na]+ 
375.2147, found 375.2150. 
8-epi-8-F3t-IsoP: 3b. 
In the same way and with 26b. (110 mg), ethylenic compound was obtained (58.4 mg; 53%). Rf = 
0.29 (9/1: Cyclohexane/AcOEt); ); [α]D20= -50.5 (c= 10, CHCl3); ν= 1737 cm-1 (C=O); 1H NMR 
(400 MHz, CDCl3): δ= 5.55-5.54 (m, 2H); 5.44-5.24 (m, 5H); 4.20 (dt, 3J(H,H) = 4.3; 2J(H,H) = 
11 Hz, 1H); 4.00 (dt, 3J(H,H) = 3.6; 2J(H,H) = 11 Hz; 1H); 3.92-3.89 (m, 1H); 3.79 (q, 3J(H,H) = 
6.7 Hz; 1H); 2.68-2.68 (m, 1H); 2.53 (ddd, 3J(H,H) = 4.3, 11.1, 15.6 Hz, 1H); 2.44-2.26 (m, 6H); 
2.10-1.84 (m, 9H); 1.78 (quint, 3J(H,H) = 5.7 Hz, 1H); 1.53 (dt, 3J(H,H) = 5.6 Hz, 2J(H,H) = 13.6 
Hz, 1H); 0.95 (t, 3J(H,H) = 7.6 Hz, 3H); 0.88 (s, 9H); 0.86 (s, 9H); 0.02 (s, 6H); 0.00 (s, 3H); -
0.01 (s, 3H); NMR (100 MHz, CDCl3): δ= 173.6 (C=O); 171.9 (C=O); 132.6 (CH); 132.2 (CH); 
131.7 (CH); 129.7 (CH); 127.7 (CH); 125.0 (CH); 75.9 (HCO-); 75.7 (HCO-); 73.6 (HCO-); 62.1 
(H2CO-); 52.4 (CH); 50.5 (CH); 44.3 (CH2); 33.6 (CH2); 32.9 (CH2); 30.4 (CH2); 26.4 (CH2); 
26.2 (CH2); 25.8 (CH3); 24.8 (CH2); 23.4 (CH2); 20.7 (CH2); 18.0 (Cquat); 17.9 (Cquat); 14.2 
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(CH3); -4.4 (CH3); -4.6 (2 x CH3); -4.7 (CH3); HRMS (ESI+) calculated for C36H65O6Si2 [M+H]+ 
649.4320, found 649.4332. 
The ethylenic compound was desilylated to obtain free hydroxyl compound (25.1 mg, 71%). Rf = 
0.3 (AcOEt); [α]D20= +62.8 (c= 10, CHCl3); ν= 3393 (OH); 1730 cm-1 (C=O); 1H NMR (400 
MHz, CDCl3): δ= 5.61 (dd, 3J(H,H) = 6.3 Hz, 2J(H,H) = 15.4 Hz, 1H); 5.53 (dd, 3J(H,H) = 8.9 Hz, 
2J(H,H) = 15.4 Hz, 1H); 5.45-5.32 (m, 5H); 4.20 (dt, 3J(H,H) = 3.3; 2J(H,H) = 11.2 Hz, 1H); 4.05-
3.97 (m, 3H); 2.81-2.78 (m, 1H); 2.54 (ddd, 3J(H,H) = 4.5, 11.2, 15.6 Hz, 1H); 2.46-2.38 (m, 
4H); 3.32-2.24 (m, 2H); 2.21-2.16 (m, 1H); 2.12-1.91 (m, 8H); 1.78 (quint, 3J(H,H) = 6.6 Hz, 
2H); 1.66 (dt, 3J(H,H) = 3.3 Hz, 2J(H,H) = 14.5 Hz, 1H); 0.96 (t, 3J(H,H) = 7.5 Hz, 3H); NMR 
(100 MHz, CDCl3): δ= 173.6 (C=O); 172.1 (C=O); 133.1 (CH); 132.0 (CH); 131.3 (CH); 130.4 
(CH); 127.2 (CH); 124.6 (CH); 76.5 (HCOH); 76.3 (HCOH); 73.4 (HCO-); 62.1 (H2CO-); 53.6 
(CH); 50.9 (CH); 42.4 (CH2); 33.6 (CH2); 32.6 (CH2); 30.4 (CH2); 26.9 (CH2); 26.4 (CH2); 24.8 
(CH3); 23.4 (CH2); 20.7 (CH2); 14.3 (CH3); HRMS (ESI+) calculated for C24H37O6 [M+H]+ 
421.2590, found 421.2588. 
The last compound was saponified to obtain 3b (19 mg, 90 %). Rf = 0.27 (AcOEt/HCO2H 95/5); 
[α]D20= -24.0 (c= 5, MeOH); 1H NMR (300 MHz, MeOD): δ= 5.57-5.54 (m, 2H); 5.51-5.44 (m, 
2H); 5.42-5.39 (m, 2H); 4.07 (q, 3J(H,H) = 5.8 Hz, 1H); 4.02-3.96 (m, 1H); 3.92-3.87 (m, 1H); 
2.73-2.68 (m, 1H); 2.50 (dt, 3J(H,H) = 7.4 Hz, 2J(H,H) = 14.2 Hz, 1H); 2.38-2.27 (m, 4H); 2.17-
2.05 (m, 7H); 1.69 (quint, 3J(H,H) = 7.2 Hz, 1H); 1.56 (dt, 3J(H,H) = 5.0 Hz, 2J(H,H) = 14.2 Hz, 
1H); 0.99 (t, 3J(H,H) = 7.5 Hz, 3H); NMR (75 MHz, MeOD): δ= 175.0 (C=O); 133.2 (CH); 130.2 
(CH); 128.9 (CH); 127.7 (CH); 125.8 (CH); 124.3 (CH); 73.4 (HCOH); 73.3 (HCOH); 70.6 
(HCOH); 50.8 (CH); 48.5 (CH); 40.6 (CH2); 33.4 (CH2); 32.3 (CH2); 25.0 (CH3); 24.3 (CH2); 
23.3 (CH2); 18.7 (CH2); 11.7 (CH3); HRMS (ESI+) calculated for C20H32O5 [M+Na]+ 375.2147, 
found 375.2169. 
 
